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ABSTRACT

ABERRANT COMMUNICATION AND PROTEIN KINASE C
IN EXPERIMENTAL AUTOIMMUNE THYROIDITIS
by
Joyce P. Lazarus

Autoimmune diseases are a worldwide healthcare concern. Research has
focused mainly on the role of the immune system and genetic susceptibility to
autoimmune disease. However, this study investigates altered target tissue properties
and their contributions to the pathogenesis of induced autoimmune thyroiditis in Lewis
rats. Our hypothesis was; inflammation-induced lymphocytic infiltration and
subsequent fibrosis results in physical disruption of gap junctional communication in
the target tissue contributing to the disease process. Our study of intercellular
communication in experimentally-induced autoimmune thyroiditis (EAT) in Lewis rats
revealed a deficiency in connexin expression, connexin assembly and dye transfer
[(results corroborated in murine model of autoimmune thyroiditis) (AT)]. Removal of
inflammatory mediators from cultures did not reestablish dye transfer despite
restoration of intimate cell contact. Thus, factors other that physical disruption were
influencing aberrant communication in EAT. By studying protein kinases, we found

pKC activity was increased in diseased thyrocytes with enhanced expression of several
pKC isozymes and induction of two disease-specific pKC isozymes. The increase in
pKC activity was not due to elevated enzymatic activity, but rather to the increased
levels of protein. We further found the enhanced pKC activity was responsible for the
reduced Connexin 43-mediated communication observed in EAT. To determine if
elevated pKC activity was linked to abnormal receptor function, we measured TSHr
expression (density), and modulated pKA activity and intercellular levels of cAMP.
We found diseased thyrocytes had an increased density of TSHr that was not directly
linked to pKC and was not responsible for the increase in pKC activity. The TSHr
linkage on the diseased cells appears to be through cAMP-pKA which we found to
function normally. Clonal FRTL-5 cells were tested for use as a control for primary
thyrocytes. We found that FRTL-5 cells do not express Connexin 43 protein and
mRNA, or communicate suggesting that the absence of Connexin 43 may be
responsible for the aberrancies in thyroid function noted in FRTL-5 cells. A
pKC-mediated loss of coordinated thyroid function contributes to AT and
hypothyroidism. Clearly, the identification of disease-causing factors that result in a
sustained participation of target tissue in EAT will be a significant accomplishment.
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CHAPTER ONE
INTRODUCTION

A. Preface
Autoimmune diseases are a worldwide healthcare concern. They include a
variety of chronic debilitating conditions that are associated with high morbidity and
mortality rates. Symptoms can vary from minor discomfort to severe progressive pain.
Autoimmune diseases are a consequence of immune responses to self proteins
(loss of self tolerance) that result in pathological sequelae. Research into the pathologic
process of autoimmune diseases has focused on the contributions of the immune system
and genetic susceptibility. However, some aspects are still not understood including
the cause of lost peripheral tolerance and therefore, why specific target tissues become
the subject of the immune attack. The role of target tissue and its contributions to the
disease process and subsequent loss of function have not been adequately studied.
Currently, target tissue in autoimmune disease is viewed as a passive victim of the
immune response (reviewed in 1,2,3,17). Our research has focused on the role of
target tissue in the disease process. We have determined that thyroid target cells have a
number of abnormalities that implicate them in the loss of function characteristic of
autoimmune thyroiditis. Clearly this is an area of research that has great potential and
needs to be more extensively studied. This dissertation investigates abnormalities in

3

4

and potential contributions of, the target tissue to the etiology of autoimmune
thyroiditis.
Cells are organized in a three dimensional configuration with extracellular
matrix and adhesion proteins participating in the formation of a contiguous, integrated
tissue. The integration of cells into organized tissue critically depends on cell-cell,
cell-matrix and matrix-matrix interactions (reviewed in 1,18). Contact-dependent
cell-cell communication is a cell-cell interaction mediated by membrane-assembled
protein channels that allow cytoplasmic continuity (4,5) and bi-directional exchange of
metabolic information (6) between coupled cells (7). Intercellular communication
enables tissue to function in a coordinated manner. This is particularly important in
endocrine glands where cells with heterologous responses to stimuli coordinate and
enhance their function through gap junctions. This coordination results in an enhanced,
more efficient release of hormones (8). The thyroid gland consists of follicular cells
that respond to thyroid stimulating hormone (TSH) binding to TSH receptors expressed
on their cell surfaces (9,10). The TSH receptor can be coupled to protein kinase A
(pKA) or protein kinase C (pKC) which activate thyrocytes to produce thyroid
hormones, tetra-iodothyronine (Thyroxine, T4) and tri-iodothyronine (T3) (11,12).
These hormones are released into the bloodstream and mediate peripheral physiologic
effects (10,13,14). Based on numerous examples (8,15) it seems reasonable that the

5

thyroid like other endocrine tissues, is potentially regulated in terms of hormonal
release by a cell-cell communication-mediated mechanism.
Cell-cell communication is mediated by protein monomers, connexins, uniting
to form hexameric hemichannels in the plasma membrane (4). Two hemichannels in
adjacent cells join to form a complete channel (connexon), spanning the plasma
membrane allowing adjacent cells to exchange signals (5). This contact-dependent
process requires proximity of cells and further interactions with extracellular matrix and ’
adhesion proteins for the correct assembly of gap junctions and tissue integrity.
Proteoglycans and adhesion proteins enhance both the degree and amplitude of gap
junctional communication (16). Proximity can be altered in autoimmune diseases as a
result of inflammatory processes.
In autoimmune diseases, tissue is infiltrated by lymphocytes and macrophages
that produce cytokines which are biologically active glycoproteins that mediate immune
responses by inducing a number of processes ranging from proliferation to proteolytic
effects (1,17). These pleiotropic effects are species- and cell-specific and result in the
inflammatory changes characteristic of tissue alteration associated with autoimmune
disease. Current models of autoimmune disease attribute the loss of function to
cytotoxic destruction of the affected tissue by cytokine-mediated events
(reviewed in 1,2,3). Our hypothesis is that lymphocytic infiltration and cytokines
cause tissue architecture disruption which interrupts contact between cells and can
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reduce contact dependent cell-cell communication. These changes can contribute to the
autoimmune process and loss of thyroid function. To test this hypothesis, we chose to
study the thyroid gland which is easily accessible and has only three cell types
(reducing the complexity). Thyroiditis presents as hypothyroidism with lymphocytic
infiltration and autoantibodies produced to various thyroid proteins (2,20,19).
We induce and characterize an experimentally induced model of autoimmune
thyroiditis in Lewis rats that mimics classical Hashimoto’s thyroiditis, and use the
model to conduct and complete the studies that comprise this dissertation. Concurrent
studies in our laboratory have also examined spontaneous autoimmune thyroiditis in
MRL-lpr/lpr mice (21).
We also examine the communication competence of Fisher rat thyroid line-five
cells (FRTL-5 cells) which are clonal cells extensively used by other laboratories to
mimic primary rat thyrocytes. The interest in FRTL-5 cells is mainly because they do
not have growth constraints (22). We conducted studies to determine whether FRTL-5
cells retain normal thyroid physiology and could be used as a corollary for our studies.
The extent to which FRTL-5 cells represent normal thyroid cells is controversial and
inconclusive (23). We chose to examine gap junctional communication because it is
ubiquitous in nature and contributes to the regulation of many important cellular
processes including metabolism, homeostasis, differentiation and growth
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(7,24,25,26,27). Our investigation of this cell line parallels many aspects of our work
in the Lewis rat model.

B. Statement of the Hypothesis
Inflammation-induced tissue disruption reduces intimate contact between cells
and decreases cell-cell communication. This loss of intercellular communication can
result in a loss of coordination of thyroid function thereby contributing to
hypothyroidism and symptoms of autoimmune thyroiditis. Therefore reflecting an
active role of the target tissue in the development of autoimmune thyroiditis. Protein
kinases that regulate intercellular communication and thyroid function may be aberrant.

C.

Background

1.

Cell-Cell Communication
Gap junctions link individual cells into contiguous tissue. Intercellular

communication is mediated by gap junctions which are specialized aggregations of
membranous protein that allow cytoplasmic continuity between adjacent cells separated
by a gap of 2-3 nm (4,5,28,29). Gap junctions consist of monomeric units called
connexins (Cxs) (4,5,6,28,29). Approximately 18 connexins have now been
identified (30). The most prevalent and best understood connexin is Connexin 43, also
believed to be the “mother” or default connexin from which other connexins have
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embryological origin (31). A new naming system is in transition, where structural
homologues are grouped as alpha (1-n) and beta (1-n) (30) in place of the present
nomenclature based on molecular weight. Connexins were originally isolated from
specific tissues with Connexin 43 in heart tissue (30), Connexin 40 and Connexin 37 in
lung tissue (32,33), Connexins 32 and 26 in liver tissue (31). However, recently
tissues have been found to express multiple connexins that appear to be regulated
differently (31,35). This implies that different connexins may serve distinct functions
which have important implications in organs consisting of multiple cell types, and that
conduct various physiological processes concurrently.
Connexin assembly into hexameric hemichannels is contact-dependent with the
joining of two hemi-channels in the plasma membranes of adjacent cells establishing the
complete connexon channel (4,5,28,29). The connexon provides continuity between
the cytoplasm of coupled cells, believed to allow the passage of small molecular weight
proteins, metabolites, ions (6,36) and second messengers that have important
consequences in the regulation of homeostasis (6,37) [see Figure 1 (38)]. Functional
capacity is dependent on the correct assembly of gap junctions. The transfer of
fluorescent dye between a microinjected cell and its contacting neighboring cells is a
functional measure of the correct assembly of connexins into gap junctions in
contacting plasma membranes. Primary transfer describes the transfer of dye to
adjacent cells in direct contact. Secondary, tertiary and quartenary transfer describes
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Figure 1. Hepatocyte gap junctions. Models of gap junction structure have the
following as common features: six symmetrical subunits across the plasma membrane
of one cell, forming a connexon that protrudes into the extracellular gap, where it
connects with a connexon of an adjacent cell, thereby forming an intercellular channel
(maximum bore of 20 A°. A cluster of these channels form a gap junction plaque
(from Makowski et al. 1977).
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dye transfer toperipheral cells not in direct contact, but separated by one, two and three
intervening cells, respectively.
It is believed that it is in this capacity intercellular communication coordinates
and integrates cooperation and regulation of physiologic processes between cells. The
development of abnormalities in growth (25,39,40,41,42), differentiation (27,43) and
metabolic cooperation (7,24,25,26) in the absence of intercellular communication for
example cancer, indicates the importance of this process for normal physiologic
function (6,17,25,37,40,44,45,46).
Contact-dependent cell-cell communication coordination is particularly
important in endocrine tissues which require synchronized responses to release
hormones (47,166). This has been demonstrated in pancreatic beta (p) cells where
inhibition of communication with heptanol markedly decreased insulin secretion
implicating a role for communication in endocrine function (48). A concurrent
increase in amylase from pancreatic acinar cells occurred when communication was
inhibited demonstrating a role in exocrine function as well (8,49,50).

2. Cell-Cell Communication in Endocrine and Exocrine cells
The contribution of gap junctional communication to endocrine and exocrine
function has not been studied until recently. A study reported the expression of
Connexin 43 and not Connexin 32 in endocrine glands like pituitary, parathyroid,
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pancreatic islets and adrenal (15). In contrast, exocrine glands express Connexin 32
and not Connexin 43 (15). This suggested that the differential expression of connexins
may specify either an endocrine or an exocrine nature to the differentiating secretory
cell (15).
The thyroid gland expresses Connexin 43, Connexin 32 and Connexin 26
(Phase 1) (21,35). Therefore the expression of Connexin 43 and Connexin 32 in the
thyroid may be because the thyroid secretes its products extracellularly into its lumen
before release into the vascular compartment (15,21,35). However, the role of
Connexin 26 is inconclusive as it is expressed at variable levels in both endocrine and
exocrine glands and is not found in porcine or dog thyrocytes (15).

3. Extracellular Matrix
Extracellular matrix (ECM) products are important components of tissue
architecture. They contribute to both the integration of cells into a syncitium and their
contact sensitivity (16,51,52). Cells must be in close proximity for contact-dependent
cell-cell communication to occur. ECM enhances epithelial-mesenchymal interactions
necessary for continuity between cytoplasm and the external environment which are
critical for intercellular communication and homeostasis. Certain proteoglycans and
adhesion proteins have been documented to contribute to and enhance established cell to
cell communication (16,51,53-58). These reports look at hepatocytes, where the
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addition of proteoglycans can re-establish communication in uncoupled cells, as well as
enhance the degree of coupling and the longevity of communication in primary
cultures (16). Adhesion molecules also contribute to organ formation and function.
An example recently reported was cadherin-mediated adhesion defined lumen formation
as thyroid cells formed follicles (59).

4. Protein Kinase C (pKC)
PKC, an important regulatory enzyme of molecular weight 77-90 kilodaltons
(kDa) was discovered in 1977 (49,60). pKC is a serine and threonine-specific protein
kinase dependent upon calcium and phospholipids for its activity (61). Using
complementary deoxyribonucleic acid (DNA) (cDNA) clones, the complete amino acid
sequence of bovine brain pKC was determined. It consists of a regulatory and a
catalytic domain interspersed with variable regions. The amino terminal is a cysteine
rich domain with an internal duplication and a phospholipid/diacylglycerol/phorbol
ester/calcium-binding site which constitute the regulatory domain (49,60). The
carboxyl terminal consists of the catalytic domain with substantial homology to
sequences of other protein kinases (61).
Studies show the existence of a pKC gene family with at least three distinct
genes and evidence of alternative splicing of these genes (49). At the last count, the
pKC family consists of 15 isoforms in three subclasses; having a common structure
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closely related to, but clearly distinct from the members of the other subclasses. The
classical isoforms are: alpha (a), betaY (Pl), betau (Pn) and gamma (y) which are
calcium (Ca2+)-activated and phospholipid-dependent. The novel isoforms are: delta
(5), epsilon (s), theta (0), sigma (a), mu (p) and eta (^) and are calcium-independent,
while the atypical lambda (X), iota (i) and zeta (Q are Ca2+-independent and not
activated by phorbol esters (12) [see Figure 2 (110)].
The ubiquitous existence of pKC and the array of protein substrates which it
phosphorylates can influence cell growth, differentiation and other responses suggests
and supports its importance in modulation and/or control of many different biological
processes. PKC is also implicated to be important in endocrine, exocrine and
inflammatory conditions (60,62,63). Prior to the discovery of the multiple isoforms it
was unclear how a single molecule could mediate and control the variety of ligand
receptor signaling systems reported to be responsive to pKC (60,62,63). The isoforms
in each subclass have distinctive structural features including highly conserved.
interspersed domains varying between the subclasses most likely defining isoform
specific biological functions (64). The diversity of responses observed may be due to
activation of one or more isoforms (37,64,65) as each isoform differs in its tissue
distribution, subcellular localization, substrate specificity and requirements for
activation (12,49,157).
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Figure 2. Structure of pKC isoforms. The classical (c), novel (n) and atypical (a)
isoform groups are schematically illustrated. Four conserved (Q to C4) and five
variable (V! to V5) regions of the cpKC group are indicated. Details are outlined in
chapter 1, A. 4. (from Yasutomi Nishizuka et al. 1992).
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Ligand-induced pKC receptor-mediated activation of phospholipase C causes the
hydrolysis of inositol phospholipids [phosphotidylinositol-4,5-bisphosphate (PIP2)] to
form inositol-1,4,5 triphosphate (IP3) and diacylglycero (DAG)l which are both second
messengers (61,66-68) [see Figure 3 (62)]. It is thought that the primary effect of
diacylglycerol is to activate pKC which in turn phosphorylates a range of specific
proteins in the cell membrane and cytoplasm. These phosphorylated products
undoubtedly exert specific cellular actions. IP3 enters the cytoplasm and appears to
stimulate the release of Ca2+ from the endoplasmic reticulum. The released Ca2+ acts
as a second messenger for a number of reactions such as the stimulation of protein
kinase phosphorylation (including activation of pKC by diacylglycerol) (66-68). pKC
inhibitors include calphostin C (70), staurosporine, chelerythrine, and k252a (69).
Some inhibitors contain a "pseudosubstrate" sequence in the catalytic domain that bind
pKC and maintain it in an inactive state (69).

5. cAMP-dependent Protein Kinase - Protein Kinase A (pKA)
The binding of a hormone to its receptor results in conformational changes that
allow the guanosine triphosphate protein (GTP)-regulatory protein to react with GTP.
Thereafter, GTP interacts with G protein-Gs coupled to adenylate cyclase to convert
adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP) (71).
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Figure 3. Schematic representation of the bifurcating pathway of signal
transduction. Variable extracellular informational signals are passed from the cell
surface into the cell interior by two routes, protein kinase C activation and Ca2 +
mobilization. Both routes usually become available as the result of an interaction of a
single agonist and a receptor, and subsequent hydrolysis of phophatidylinositol 4, 5bisphosphate. The resulting products, 1, 2-diacylglycerol and inositol 1, 4, 5triphosphate, act as second messengers for pKC activation and Ca2+ mobilization,
respectively (from Yasutomi Nishizuka et al. 1988).
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The concept of cAMP as an intracellular second messenger of hormone action
and the discovery of cAMP-dependent protein kinase was of Nobel Prize winning
merit. cAMP-dependent protein kinase has a tetrameric structure [R2C2 consisting of
two monomeric catalytic subunits (C) and a dimeric regulatory subunit (R)] (72-74)
linked by disulphide bonds (72). The catalytic subunit has a molecular weight of
40 kDa (72). Two types of cAMP-dependent protein kinases; type I and type II have
been documented that differ in the characteristics of their regulatory subunits
(RI and RII) which are 47 kDa and 54 kDa respectively (73). Activation of pKA
occurs by the binding of cAMP to the regulatory subunits resulting in dissociation of
the holoenzyme (inactive R2C2) to a regulatory subunit dimer-cAMP complex and two
active catalytic subunits (74-76).

R2C2 (inactive) + 4 cAMP

R2C2-cAMP2 + 2C (active)

The free form of the catalytic subunit is able to phosphorylate substrate
proteins (73). It appears that the holoenzyme is also capable of phosphorylation (77).
It has been demonstrated that cAMP activates protein kinase A (72). This leads to a
series of phosphorylations of other proteins resulting in the physiologic cellular
functions of the hormone that bound its receptor and activated this cascade (72). For
example, catalytic subunits and cAMP can translocate to the nucleus where: 1) cAMP
binds to its nuclear binding proteins (CREBs) which then bind to cAMP response
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elements (CREs) in the promotor region of cAMP- responsive genes to induce
transcription (78,79) and 2) catalytic subunits may phosphorylate nuclear proteins and
induce similar gene-transcription through CREs which contain a conserved 8 base
palindrome (37,78).

6. Regulation of Cell-Cell Communication
Gap junctions are regulated at all levels of formation and function by
Ca2+and/or H+ ions, voltage or protein kinase-mediated phosphorylation events
(reviewed in 80,81). This regulation can occur at many different levels including: gene
transcription, posttranscriptional modification, regulation of translation and
post-translational modification, regulation of translational product half-life, regulation
of connexin insertion into membranes and regulation of hemichannel opening and
closing (37,81). Gap junctions rapidly change from open (functional) to closed
(non-functional) states. This is termed “gating”. Connexins are regulated differently.
with phosphorylation coordinating Connexins 43 and 32 but not Connexin 26
(80,82-86). The regulation of Connexin 26 has not been confirmed.
Several phosphorylated forms of Connexin 43 have been identified, including
Connexin 43-NP (non-phosphorylated), and 44 kDa and 46 kDa denoted
Connexin 43-PI and Connexin 43-P2 respectively (84). Often, communicationcompetent cells convert Connexin 43-NP to Connexin 43-P2, a triton-insoluble form
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which is found in the plasma membrane (88,89). It appears phosphorylation is
consistently associated with functional gap junctional plaques indicating the necessity of
phosphorylation events mediated by protein kinases for communication to
occur (4,37,90).
L Regulation of Connexin 43-mediated Communication by Protein kinase A (pKA)
Connexin 43-mediated communication is most often upregulated by cAMP and
its activity through cAMP-dependent protein kinase A (pKA) (91,92) increasing the
area of membrane involved in gap junctional formation (91,92) and the degree of dye
transfer (an increase in the number of open channels) (93). Many peptide hormones
and their specific receptors function via the activation of cAMP-mediated second
messenger systems (7,94,95). Studies have demonstrated an enhanced dye transfer in
primary thyrocytes treated with TSH or cAMP analogs (96) and in porcine ovarian
granulosa cells when treated with follicle stimulating hormone (37,97).
ii. Regulation of Connexin 43-mediated Communication by Protein kinase C (pKC)
In numerous studies on cultured cells the activation of pKC pathways have been
implicated in the reduction of Connexin 43-mediated intercellular communication (98).
Pharmacologic agents for example, 12-0-tetradecanoyl phorbol ester 13-acetate (TPA)
activate pKC in a sustained manner (60,63,99-101) while
l-octoyl-2-acetylglycerol (OAG) is a diacylglycerol-analogue that activates pKC in a
more physiologic manner (100). It appears TPA inhibits the assembly of Connexin 43
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gap junctions but does not alter channel gating nor enhance disassembly of gap
junctional plaques (101).
Other studies have demonstrated an increase in Connexin 43-mediated
communication with pKC activation in rat myocardial (102,105), sertoli cells and
human corpus cavernosum cells (103,104). The regulation of cell-cell communication
appears to have been initially oversimplified as recent information suggests the
involvement of other kinases acting to regulate connexin expression and function (106).

7. The Thyroid
The thyroid gland is a small gland located in the neck anterior to the trachea. It
is a bi-lobed organ connected by an isthmus. The thyroid gland is an endocrine gland
producing hormones T4 and T3 by follicular cells and calcitonin by parafollicular cells.
The biological effects of T4and T3 are extensive; increasing body temperature, oxygen
consumption, metabolism of carbohydrates, modulating other hormones and affecting
the mental state (9). Calcitonin regulates calcium levels very precisely for optimum
physiological function (9).
The thyroid consists of three cell types; epithelial cells predominantly (70%),
vascular endothelial cells (20%), fibroblasts (10%) and sparse C cells (Figure 4) (109).
The follicular cells are organized into single layer sac-like structures enclosing cavities.
Fibroblasts and parafollicular cells are organized outside the follicle (9,14).
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Figure 4. Synthesis of Thyroid Hormones. Illustration of the polarity of thyrocytes.
Iodine is actively absorbed from the basal surface of the cell, processed to form T3 and
T4, and at the apical surface, released into the colloid. The hormones are released by
reabsorption and cleavage of Tg in the cell (from Prize et al. 1986).
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i. Thyroid Regulation
Thyroid function is mediated by a cortex-hypothalamus-pituitary-thyroidperipheral tissues axis (107). Thyrotropin releasing hormone (TRH) is produced in the
hypothalamus and stimulates the release of TSH (thyrotropin) by the anterior pituitary
into the bloodstream. TSH binds its receptor, thyroid stimulating hormone receptor
(TSHr) which is expressed on follicular cell surfaces to mediate thyroid
function (9,10). Negative feedback mechanisms regulate hormonal release at each level
of this axis (9).
ii. Thyroid Stimulating Hormone (TSH)
TSH consists of a and (3 subunits. The [3 subunit is specific to TSH while the
a subunit is common to follicular stimulating hormone and luteinizing hormones (108).
Ligand-receptor interaction mediates a series of events culminating in the synthesis and
release of T4 and T3 (9).
Hi. T4 and T3 Synthesis
Iodine is actively transported from the bloodstream (basolateral membrane) into
the follicular cell and oxidized by thyroperoxidase (TPO) to iodide, which iodinates
tyrosine groups forming mono- and di-iodotyrosines which are coupled to form
tri-iodothyronine and tetra-iodothyronine. T4 and T3 are stored in thyroglobulin (Tg)
and released as needed (Figure 4) (109).
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Tg and thyroperoxidase are assembled from amino acids forming polypeptides
on the rough endoplasmic reticulum and carried to the golgi complex where a
carbohydrate moiety is added to form glycoproteins (109). Non-iodinated Tg is
released from the apical surface of the follicular cells into the follicular lumen along
with mucopolysaccharides and proteolytic enzymes to form a colloid (109). The
colloid is endocytosed and undergoes proteolysis to release Tg-bound T3 and T4 in
addition to mono- and di-iodotyrosines (87,116). T4 exists as both bound and free
forms with the free form physiologically active. The iodinated tyrosines are
deiodinated to recycle the iodine (109).
iv. Thyroid Stimulating Hormone Receptor
The TSH receptor is a G-protein coupled receptor with seven transmembrane
spanning regions, a large extracellular domain and a short cytoplasmic
portion (9,10,111). Evidence for TSH being the major modulator of thyroid cell
function is illustrated by the pathological consequences of abnormalities in these
receptor-ligand interactions (10,13,14,112). Under physiologic conditions in normal
rat thyrocytes and FRTL-5 cells, the TSH receptor appears to be linked to the
G protein-Gs, which activates the enzyme adenylate cyclase and releases cAMP
(9,12,96). cAMP activates pKA to elicit many of the known physiological functions of
TSH such as protein iodination, thyroid hormone synthesis and thyroid hormone release
(9,113,114). At higher concentrations of TSH (3x in dog thyrocytes and FRTL-5 cells
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and lOx in human thyrocytes) the Ca2+ -sensitive phosphoinositol dependent pKC
pathway, G protein-Gp linked, appears to be activated (115). The existence of two
receptors is a possibility but studies on CHO cells transfected with human TSHr cDNA,
have demonstrated that this single receptor can activate both pKC and pKA pathways
(115-117). This indicates the TSHr can alternatively be associated with either the pKC
or pKA pathways.
A study looking at the mitogenic and antimitogenic effects of TSH and cAMP
on rat and dog thyrocytes showed that early in culture, the cells responded to both
agents mitogenically (increased DNA synthesis) which ultimately induced cell
division (11). TSH appeared to induce cell differentiation and subsequent activities; T3
secretion and iodide uptake when cell growth was reduced in later stages of
culturing (11). The divergent effects of TSH on cell multiplication were presumed to
be a result of a “switch” of the TSHr from pKA activation to other mechanisms like
pKC activation (11,118).
It is not yet clear what factors or regulatory mechanisms mediate this switching.
A possibility is that the link to both these pathways is related temporally wherein
primary thyrocytes can change from pKA activation to pKC as a function of the
number of cell divisions (11). An intrinsic property of the receptor itself may be
responsible, for example a lower affinity of the occupied TSH receptor for Gp than for
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Gs or due to different posttranslational processing (119). Different populations of Gp
and Gs in different cell types or under different physiologic conditions may also
influence which cascade is activated (119). A report using v-ras transformed FRTL-5
cells, indicated that pKC activation inhibited nuclear migration of the catalytic subunit
of pKA and consequently inactivated thyroid-specific transcription factors dependent on
phosphorylation by pKA, thus resulting in a reduction in transcription of thyroglobulin
and a loss of cell differentiation (120). Another pKA to pKC activation switch was
documented by varying Ca2+ concentrations (81). When the pKA cascade was
activated, cAMP induced a Ca2+ influx in addition to the Ca2+ already present. If
initial Ca2+ levels were greater than 6 mM, the sum of the initial level and the
additional Ca2+ influx was apparently adequate to activate pKC. However, if initial
Ca2+ levels were lower than 4 mM, the sum of the additional Ca2+ influx was not
sufficient to activate pKC. Therefore, a switch from pKA to pKC does not occur (81).

8.

Immune Response and Self Tolerance
An immune response is normally initiated by the recognition of substances

viewed as “non-self’ or foreign. These foreign substances (antigens) are complexed
with MHC molecules and are presented to T lymphocytes (20). Normal immune
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function involves the recognition and ability to distinguish foreign antigens (“non-self”)
from “self” antigens and evoking an immune response only to the non-self
antigens (20). The current view is that autoimmune diseases occur when self antigens
are no longer recognized as self, resulting in an inappropriate immune response (20).
i. Antigen Presentation
Immune responses, against self or foreign proteins require initiation by
presentation of the antigen to T cells (20). The antigen is first taken up via receptors
by antigen presenting cells (APC) (64), processed into peptides (epitopes) and
complexed with major histocompatability complex (MHC)-encoded molecules (20).
Antigens complexed with MHC class I molecules usually stimulate cytotoxic
T cells which kill the cell presenting the antigen (e.g. a virus), while antigens
complexed with MHC class II molecules stimulate T helper/inducer T cells (20). The
complex of MHC molecule-antigen alone is insufficient for T cell activation and often
needs adhesion molecules and costimulators. Adhesion molecules (e.g. CD4+ and
CD8+) increase the binding of the T cell to the APC molecule and enhances the
strength of interaction which is a major determinant of whether the antigen will be
recognized to transduce a signal (20,121). Costimulators (cytokines like IL-1) activate
and cause T cells to divide resulting in an enhanced immune signal (20).
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ii. T Cell Stimulation and Function
T cells express T cell receptors (TCRs) 90% of which are composed of
alpha (a) and beta ((3) chains and 10% composed of gamma (y) and delta (5)
chains (20). TCR is restricted in its recognition to both peptides and MHC molecules
which are extracellular (20). The CD3 complex is a cytoplasmic signal transducing
accessory protein of the TCR (20). The TCR chains are encoded by a large number of
variable (V), diversity (D), joining (J) and constant (C) gene segments which in various
combinations yield tremendous diversity (20). Restricted use of certain variable
segments by autoreactive cells has been demonstrated in experimentally induced
autoimmunity wherein only T cells which bear a select variable segments are
autoreactive (20). Therefore, the identification of these select few variable segment
usage by TCRS in disease may be important. Various therapeutic possibilities were
explored as a result of the discovery of variable segment restriction. These included:
1) blocking the V (3 chains with monoclonal antibodies, 2) deletion of critical T cells.
3) vaccination with the autoreactive TCR to induce CD8+-resistance to autoimmunity.
4) induction of regulatory T cells and 5) the creation of modified antigen peptides to
prevent the interaction between disease-specific TCR and autoantigen complex. Such
efforts have failed because of: 1) the difficulty in identifying the variable segments used
by T cells in autoimmune diseases, 2) the restriction of autoreactive T cell clones, 3)
problems with PCR (polymerase chain reaction) used in identifying V gene restriction
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and 4) because autoreactive cells respond to more than one epitope on an autoantigen
thereby complicating these investigations (20).
Hi. Induction and Maintenance of Self Tolerance
It is in the thymus during T cell maturation, a large number of self reactive
T cells are thought to be controlled by physical elimination (clonal deletion) or
functional silencing (clonal anergy) (20). Clonal deletion depends on recognition of
antigen-MHC class II molecule complexes with subsequent elimination of T cells.
Clonal deletion may fail due to intrinsic inefficiency or a failure to express certain
autoantigens in the thymus (20). Clonal anergy is achieved by presentation of self
antigen-MHC complexes in the absence of an essential costimulator (20).
In cases where antigens have not been recognized in the thymus during early
life, self tolerance may develop in the periphery termed peripheral tolerance. The
mechanisms are similar to those proposed to occur in the thymus; lack of recognition of
antigens by T cells or the lack of costimulators. For example, the expression of MHC
class II molecules on cells including thyrocytes, which normally do not express them
lack the costimulator and has the potential to control autoreactive T cells recognizing
self antigens absent from the thymus (20). This would prevent self reactivity and result
in self tolerance. It is a failure to develop self tolerance that results in autoimmune
disease (20).
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9. Autoimmune Thyroiditis
The development of autoimmune thyroiditis appears to be the result of a
combination of predisposing and environmental factors but is ultimately considered to
be antigen driven and T cell mediated (1). AT encompasses a spectrum of clinical
presentations ranging from no symptoms to severe hypothyroidism (125). The
pathology is also varied with extremes ranging from large goiters with major
lymphocytic infiltration and clearly defined lymphoid follicle centers, to fibrotic
atrophic glands (Reviewed in 125). The infiltrating lymphocytes are usually
differentially distributed with T-cells predominantly localized in interthyroidal spaces
and B-cells often polyclonal, immunoglobulin (Ig)-positive and organized into
lymphoid follicle centers (125).
A variety of circulating anti-thyroid auto-antibodies (Abs) are present and
directed against various thyroid epitopes (126). However, disease onset or severity is
not always correlated with the presence of circulating Abs to self-reactive
components (127). This is exemplified by anti-thyroglobulin (anti-Tg) Abs that can be
detected in the sera from non-thyroidal diseased and healthy individuals, thereby,
preventing their use as a diagnostic indicator of thyroid disease. There are other anti
thyroid component auto-Abs that have a much higher predictive value (128).
Thyroperoxidase is a specific microsomal enzyme which functions in the processing of
Tg to thyroid hormones, (T3) and (T4) (129). Circulating anti-TPO auto-Abs correlate
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with lymphocytic infiltration of the thyroid in greater than 98% of patients with thyroid
dysfunction and is being increasingly used as a definitive serological indicator of
thyroiditis (122,130).
Thyroid follicular cells in thyroiditis, and other cells residing at sites of
autoimmune reactivity, have an induced up-regulation of human leukocyte
antigen (HLA) class-II on their surface {murine equivalent H2 la) (125,131). The
control of B-cell maturation and immunoglobulin class switching largely depends on
helper T-cell function, which is, in turn, dependent on HLA class-II expression (132).
In pathologic states, in vivo, self-reactive helper T-cells probably also exert control
over pathogenic Ab production. The ability to induce AT through the transfer of
thyroid-reactive T-cells, in animals, demonstrates their dominant role in the disease
process (133), and has led to T-lymphocytes becoming a focus of experimental models.
Analysis of the T cell receptor (TCR) polymorphism on thyroid-reactive T lymphocytes
in humans revealed a restricted expression with respect to the number of
TCR-variable (V)-alpha alleles represented, with no apparent restriction of the
TCR-V-beta allelic frequency (134). Experimental autoimmune thyroiditis can be
induced in animals by immunization with heterologous-Tg (135). This results in the
production of pathogenic anti-Tg and anti-TPO Abs (135) which are predominantly of
the IgG-class (136). In contrast, anti-Tg Abs isolated from non-thyroidal diseased or
healthy individuals are often IgM and non-cytotoxic (137). EAT in mice has also been

35

accomplished by transferring T-cells derived from thyroid lesions into sub-lethally
irradiated mice, reconstituted with selective T-cell populations (138). Analysis of the
TCR on thyroid reactive T-cells, from adoptive transfer studies (138,139) and induction
with Tg (135,140), revealed a restriction of the number ofTCR-V-beta alleles
expressed. Interpreting the restriction that occurs in EAT is hampered by the induction
process, which significantly alters the resident T-cell populations (131). However,
nonobese diabetic mice developing spontaneous AT were also found to be restricted in
their usage of TCR-V-beta segments. On the other hand, EAT in Lewis rats in contrast
to other AT models, expressed increased levels of MHC class II in diseased thyroid
cells similarly to human AT (19,131). Currently, it is therefore the model that best
mimics human Hashimoto's thyroiditis.

10.

Clonal Cell Lines
Clonal cells are extensively used in research because they lack the growth

constraints of primary cells. The process of developing clonal cell lines involves
selecting cells that lose their growth properties and continue to divide in culture, but
retain other physiologic properties characteristic of that cell type.
FRTL-5 cells are used to mimic primary thyrocytes in thyroid research while
fetal rat lung (ERL) cells are used in the research of gap junctional communication as
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these cells are very communication competent with quartenary dye transfer and
expressing Connexin 43 (7).

D. Objectives
Phase I of this dissertation was designed to: a) characterize the extent of induced
EAT in Lewis rats and b) determine if tissue disruption occurring in experimentally
induced autoimmune thyroiditis resulted in deficient contact-dependent cell to cell
communication. Preliminary data demonstrates gap junctional communication
deficiencies exist in autoimmune-diseased thyroid cells compared to non-diseased cells.
Phase II investigated the principle regulators of communication; protein kinase
C and protein kinase A assessing their basal activities to determine if these kinases were
abnormal in EAT and/or contribute to intercellular communication deficiencies.
Phase III integrated different aspects of this research on autoimmune thyroiditis
to reach some conclusions. It was designed to: 1) investigate the secretion of
thyroglobulin from thyrocytes in the context of their metabolic activity; 2) analyze the
activation cascade of protein kinase A to determine if second messenger (cAMP) levels
were abnormal or aberrant in diseased thyrocytes and 3) determine TSH receptor
expression to see if it could be responsible for mediating the disease process.
Phase IV conducted parallel studies in a clonal rat cell line, FRTL-5 cells, to
determine if these cells maintain their thyroid properties in the context of gap junctional
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communication. This is important as these cells are extensively used in thyroid
research based on the premise that they mimic primary thyrocytes.

:

CHAPTER H
METHODS and MATERIALS

A. PHASE 1: Characterization of Disease and Reduced Cell-Cell
Communication in Experimentally Induced Autoimmune Thyroiditis.
These are methods and materials used to conduct the studies in Phase 1.
1. Lewis Rats
Female Lewis rats were purchased from Harlan Sprague Dawley, Inc. (Indianapolis, IN) at
12 weeks of age and housed under sterile conditions at the J.L. Pettis Memorial Veterans
Medical Center Animal Research Facility, Loma Linda, California. All animal care and
treatment procedures were in accordance with the current animal welfare act.

2. Induction of Experimental Autoimmune Thyroiditis
EAT was induced in Lewis rats by injection of thyroid extract prepared from freshly
isolated thyroid glands of Sprague Dawley and Lewis rats. Thyroid glands were sonicated at a
maximum setting in sterile water and centrifuged at 30,000 X g to remove the plasma
membrane and insoluble material. This extract was supplemented with purified bovine Tg
(100 mg/ml) (Sigma, St. Louis, MO). The thyroid extract and Tg mixture was emulsified in
Freunds complete adjuvant (1:1 v/v) and 0.1 ml given subcutaneously (SC) and intramuscularly
(IM) to 3 month old rats. The subsequent injections were administered in a similar manner on
days 12, 28, 60 and 75 except that incomplete Freunds adjuvant was used.

38

39

3. Tissue and Serum Samples
The rats were euthanized by carbon dioxide (CO2) asphyxiation and whole blood
removed by cardiac puncture prior to surgical removal of the thyroid gland. Serum was
removed from the whole blood by cooling the blood to 4° C and centrifuging at 3000 rpm for 5
minutes to yield a serum supernatant that was stored at -70° C.
The thyroid glands were taken immediately to the pathology laboratory for
cryosectioning. The fresh-frozen tissue was sliced in approximately 5 micron sections starting
from the outer edge of the lobe proceeding toward the isthmus. Cut sections were placed on
poly-L-lysine coated microscope slides and stored desiccated at -70° C.

4. Histologic and Serologic Determination
i. Hematoxylin and Eosin Staining Procedure
Fresh frozen cryosections were removed from -70° C and placed in room
temperature 2% paraformaldehyde solution for 15 minutes with mixing. The fixed
sections were washed in phosphate buffered saline (0.14 M NaCh, 8 mM Na2HP04,
1.4 mM NaHyPO^FhO, pH 7.2) (PBS) and stained with hematoxylin and eosin using
standard procedures (141).
ii. Free T4 Fluorometric Enzyme Immunoassay
Supernatants were tested for free T4 concentrations using a Straus fluorometric
enzyme assay (Baxter Diagnostics, Deerfield, IL). All analysis was performed by the
microprocessor-linked fluorescence analyzer.
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Hi TSH Fluorometric Enzyme Immunoassay
Serum concentration of thyroid stimulating hormone was determined by a Straus
Ultra-sensitive TSH assay procedure (Baxter Diagnostics Inc., Deerfield, IL). The method is
based on a three-site sandwich immunoassay with data analysis performed by the automated
microanalyzer (142).
iv. Enzyme-linked Immunosorbent Assay (ELISA) for the Detection of
Anti-Thyroglobulin Antibodies in Serum
Sera from the rats were screened for anti-Tg Ab using a solid phase ELISA that we
developed. This involved the binding of bovine Tg (Sigma, St. Louis, MO) to a 96-well plate
at a concentration of 50 ng/well in coating buffer. The plates were incubated overnight at 4° C
and washed three times with PBST (PBS containing 0.5% Tween-20), prior to use. Rabbit
anti-human Tg (Biomeda, Foster city, CA), and mixed normal human sera were used as
positive and negative controls, respectively. A starting dilution of 1:50 in PBS (0.14 M NaCl2,
8 mM Na2HP04, 1.4 mM NaH2P04.H20, pH 7.2) was used for all sera, followed by two-fold
serial dilutions. The plates were incubated at room temperature for 45 minutes, washed with
PBST and peroxidase-labeled goat anti-rabbit, rat or human IgG Ab added. The plates were
washed with PBST and 100 ul of TMB (3' 5, 5'-tetramethylbenzidine) substrate added to all
wells (purchased from Kirkegaard and Perry Laboratories Inc. Gaithersburg, MD). The plates
were allowed to stand for 10 to 20 minutes for complete color development and the optical
density read on a microplate spectrophotometer at a wavelength of 620 nm.
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v. Enzyme-Linked Immunosorbent Assay for the Detection ofAnti-Microsome
(Thyroperoxidase) Antibodies
An ELISA kit for the detection of human Ab to TPO was purchased from General
Biometrics (San Diego, CA). Reagents specific for rat anti-TPO are not readily available but
previous studies showed that rat anti-TPO Ab specifically binds to recombinant human
TPO (143). Basically the kit provides 96 well microtiter plates that have been pre-coated with
an unstated amount of recombinant human-TPO. A high titer (1:100, equivalent to 850IU)
anti-TPO human control sera is provided along with a negative control, anti-human conjugate
(secondary Ab), wash buffer and substrate.
The kit was modified for use with rat sera by changing the conjugate from anti-human
to peroxidase-conjugated anti-rat IgG specific secondary Ab. The rat sera was titrated with a
starting dilution of 1:50. The controls were run in duplicate two fold serial dilutions to provide
a standard curve from which the rat titrated values were calculated. TMB, the substrate and
was allowed to react 10-20 minutes to insure complete color development and the optical
density read at a wavelength of 620 nm.

5. Immunocytochemistry on Fresh Tissue Sections
Cryosections were fixed in -20° C absolute ethanol for 15 minutes and rehydrated in
PBS for 5 minutes prior to the addition of primary antisera. MHC class II protein expression
was determined using an undiluted murine hybridoma supernatant specific for rat MHC class II
antigens (Harlan, Bioproducts for Science, Indianapolis, IN). Connexin 43 was localized with
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rabbit anti-Connexin 43 antisera, CT-360, generated against amino acids 360-381 of
Connexin 43 (144). Rabbit antisera to Connexin 32 and Connexin 26 were generated against
synthetic peptides from the cytoplasmic sequences of the respective proteins (145). The
fixative procedure solubilized the plasma membrane sufficiently to allow access of the antisera
to epitopes in the cytoplasm, but provided no cross-linking properties so that infiltrating cells
were not retained in the sections. Cryosections were incubated with primary antibodies for
16-20 hours at 4° C, after which the sections were washed in PBST and incubated with the
appropriate fluorescein immunoglobulin tagged conjugated (FITC) secondary antibody.
Secondary localization of MHC class II protein was done with FITC-affinity purified goat
anti-mouse IgG, and localization of connexins was done with FITC-affinity purified goat
anti-rabbit IgG secondary antibody (10 mg/ml) (Accurate Scientific, Westbury NY). The slides
were incubated with secondary antibody for 90 minutes at 25° C, and then washed in PBST
and sealed with coverslips for fluorescent microscopic analysis and photography. Non-specific
fluorescence was determined by incubating tissue sections with non-immune sera and
secondary antibody or with secondary antibody only.

6. Molecular Biology
L RNA Extraction
RNA was extracted from tissue using standard procedures as described by Davis
et. al. (146). Briefly, the thyroids were trimmed free of extraneous tissue, sliced into pieces,
rinsed in serum free media and the tissue pellet frozen in liquid nitrogen. The frozen tissue was
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ground with a mortar and pestle with dry ice, transferred to a 50 ml conical tube and sonicated
in the presence of guanidine thiocyanate (GIT) (10 ml/0.5 gm tissue). The RNA was extracted
from the GIT-cell lysate with phenol followed by alcohol precipitation and quantitation of RNA
by spectrophotometry (A260/A280).
il cDNA probes
The cDNA containing plasmids were obtained from Drs. Eric Beyer and Dan
Goodenough (Connexin 43), Drs. David Paul and Dan Goodenough (Connexin 32), and Dr.
Bruce Nicholson (Connexin 26). The plasmids were heat-shock transformed into competent
cells, grown for quantity, extracted and the cDNA inserts excised from the plasmids using the
appropriate restriction endonucleases. 50-200 ug of cDNA insert was 32P-labeled using a
standard random priming technique (147).
Hi Northern Blot Analysis
1% agarose gels containing approximately 20 mg of total RNA were electrophoresed
at room temperature (22-24° C) in circulating running buffer, then transferred to Hybond-N
membranes, and ultraviolet (UV) cross-linked by a 4 minute exposure to 300 nM irradiation.
The membranes were stained with methylene blue and the ribosomal bands marked and
photographed. The blots were hybridized with alpha-32P-cDNA probes at 42° C for 36 hours.
washed (twice in 6X SSPE at 42° C for 15 minutes/wash), placed on film and developed after
a 1-3 day exposure. Grain densities were quantitated densitometrically and corrected for
differences in the total RNA loaded per lane.
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7. Primary Tissue Culture
Thyroids were removed asepticaUy and immediately washed in Hank’s balanced salt
solution (HESS) (Gibco, Grand Island, NY) containing penicillin, streptomycin and fungizone
(50 mg/ml, Gibco Grand Island, NY). The tissue was finely minced and incubated for 60
minutes at 37° C in 2 mg/ml collagenase (Boehringer Mannheim, Indianapolis, IN) with
continuous stirring. The resulting cell suspension was removed from undigested thyroid tissue
by gravity sedimentation and the pellet placed in fresh collagenase for an additional 60 minutes.
The cell suspension was >80% single cells with the remaining cells in the form of five
to ten cell clusters. The two collagenase-digested supernatants were pooled, centrifuged at
500 rpm for 5 minutes and re-suspended at approximately 1X105 cells/ml in Dulbecco's
modified Eagle's medium (DMEM):Hams F-12 medium (Gibco, Grand Island, NY)
(50:50 v/v) supplemented with glutamine, 10 ng/ml somatostatin, 10 ug/ml insulin.
10 nM hydrocortisone, 5 ug/ml transferrin, 10 ng/ml Gly-Lys-His, lx penicillin/streptomycin.
5% bovine calf serum (BCS) (Gemini, Calabasas, CA) (22). The cells were then seeded in 12
well tissue culture plates containing 12x12 mm glass coverslips coated with type I collagen
(Upstate Biotechnologies, Lake Placid, NY) for immunocytochemistry or in 35 mm dishes with
25 mm collagen coated glass coverslips for microinjection studies. The cells were incubated
undisturbed at 37° C in 5% CO2 for 2 days, followed by a media change to reduce the BCS to
1.5%.

45

8. Immunocytochemistry on Cultured Thyroid Cells
The cultured cells present on 12 xl2 mm coverslips were fixed and immunolabeled for
Connexins 43, 32 and 26 as described in Immunocytochemistry on Fresh Tissue Sections
(A. 5) above.
Additionally, Tg was localized with primary antisera rabbit polyclonal anti-human-Tg
antisera (Biomeda, Foster City, CA) and FITC-afifinity purified goat anti-rabbit IgG secondary
antibody (15 mg/ml) (Accurate Scientific, Westbury, NY).

9. Microinjection of Cultured Thyroid Cells
The electrophysiologic measurements were done as previously described (102). Each
coverslip culture was used for a period not exceeding 30 minutes, during which time pH
remained stable at 7.2-7.4. Microelectrodes were filled tip-to-shank with 2% (w/v) Lucifer
Yellow in 150 mM lithium chloride and back-filled with the same diluent. Dye was injected
with 100 ms pulses at 1 Hz for 5 seconds using standard electrometers (WPI 727) and 2.5nA
cathodal current. All observations and microinjections were done on a Zeiss IM-405 optical
base (Zeiss USA, NY) equipped with a side-port mounted silicon intensified target (SIT)
camera (Dage Model 66 Seimens Tube). The camera was connected to a high resolution
video-data recorder (A.R. Vetter Company Model 875) and to a video image processing
system (Image I-AT Universal Imaging) in a microcomputer base (Zenith AT). Fluorescence
images were captured using 128-frame summation with identical contrast functions for all
images within an experiment.
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10. Statistics
Serum measures were expressed as group means +: standard deviation (SD).
Student's 't' test was used to determine significant differences between EAT and control
rats for the following parameters: serum anti-Tg and anti-TPO autoantibodies, free T4,
TSH levels in thyrocytes isolated from thyroid tissue. Intercellular dye transfer was
expressed in terms of the % of trials exhibiting three degrees of dye transfer. Chi-square
analysis was used to determine significant differences in intercellular dye transfer between
treatment groups.

B. PHASE 2: Enhanced levels of Protein Kinase C Isoenzymes in Experimental
Autoimmune Thyroiditis Prevent the Assembly of Connexin 43 Gap Junctions
and Reduce Intercellular Communication.
These are methods and materials used to conduct the studies in Phase 2.
1. Models and Induction of Experimental Autoimmune Thyroiditis
As described in Lewis Rats (A. 1) and Induction of Experimental Autoimmune
Thyroiditis (A. 2) above.

2. Primary Tissue Culture
Primary cultures were established as described in Primary Tissue Culture (A. 7)
above.
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3. Immunocytochemistry on Fresh Tissue Sections
This has been described in Immunocytochemistry on Fresh Tissue Sections (A. 5)
above. The antibodies have changed as different proteins were immunolabeled.
Protein kinase C isoforms; a, [3, 5 and s were localized with murine monoclonal
primary antibodies specific for each isoform (Transduction Laboratories, Lexington, KY)
and affinity purified FITC-conjugated goat anti-mouse IgG secondary antibody (5 mg/ml)
(Life Technologies, Gibco, Brl, Grand Island, NY).

4. Immunocytochemistry on Cultured Thyroid Cells
The cultured cells present on 12 x 12 mm coverslips were fixed and labeled for
Connexin 43 as described in Immunocytochemistry on Fresh Tissue Sections (A. 5).

5. Protein Kinase C Activity Assay on Isolated Thyroid Cells.
Thyroid cell digests from control and experimental rat thyroid tissue were obtained
as described in Primary Tissue Culture (A. 7) above and divided into 50,000 cells per
sample. The assay was performed as described in kit (pKC assay, Life Technologies,
Gibco, Brl, Grand Island, NY). The assay measures the incorporation of 32P-labeled
gamma phosphate groups into the substrates.
The cells were resuspended in 200 ul of pKC extraction buffer [20 mM Tris pH 7.5,
0.5 mM ethylene diaminetetraacetic acid (EOTA), 0.5 mM ethylene glyco-bis-tetraacetic
acid (EGTA), 10 mM BME, 0.5% Triton X-100, 25 ug/ml Aprotinin and Leupeptin) and
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lysed by sonicating (at power setting 4) for 20 seconds. The lysates were incubated on ice
for 30 minutes and a 30 ul aliquot taken to determine protein concentration (148). To
separate the phospholipid from the cytosol the lysates were centrifuged at a maximum
setting (micro-centrifuge) for 10 minutes, and the supernatant transferred to fresh tubes.
Assay tubes were prepared in triplicate for each sample (25 ul cell lysate), with and without
added micelles (pre-prepared by mixing 0.5 mg phosphatidylserine, 0.5 mg
phosphatidyl inositol and 0.1 mg diolein) (Sigma Chemical Co., St. Louis, MO) and
incubated at room temperature for 20 minutes (149). The samples were then incubated
with substrate solution (2-2.5 uCi gamma^2V-&IV in 50 uM acetylated myelin basic
protein, 20 uM ATP, 1 mM calcium chloride (CaCL), 20 mM magnesium chloride
(MgCl2) and 20 mM Tris pH 7.5) for 5 minutes at 30° C. The reaction was stopped by
spotting 25 ul of each sample onto phosphocellulose disks. Control discs were spotted with
32P- substrate solution as a measure of total dpm. Disks were washed twice in 1 %
phosphoric acid, and twice in triple distilled water (5 minutes/wash) prior to scintillation
counting. The activity in picomoles per minute per milligram of protein was calculated.

6. Protein Kinase A Activity Assay on Isolated Thyroid Cells.
Thyroid cell digests from control and experimental rat thyroid tissue were obtained
as described in Primary Tissue Culture (A. 7) above. The cells were resuspended in 150 ul
of pKA extraction buffer (5 mM EDTA, 50 mM Tris, pH 7.5) and lysed by sonicating
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(at power setting 4) for 20 seconds. The lysates were incubated on ice for 30 minutes and
a 30 ul aliquot taken to determine protein concentration (148). The lysate was centrifuged
at maximum speed in a microfuge for 10 minutes and the supernatant transferred to fresh
tubes. The assay was performed similar to that described by Whitehouse and Walsh (150).
Briefly, each lysate was divided into 4 tubes, 2 received 10 mM cAMP and 2 received
nothing. The samples were assayed in the presence of substrate solution (50 uM Kemptide)
(Sigma Chemical Co., St. Louis, MO), 100 uM ATP, 10 mM MgCL, 0.25 mg/ml bovine
serum albumin (BSA), 50 mM Tris, pH 7.5) containing approximately 2-2.5 uCi
gamma-^V-MTV. Incubations were done at 30° C for 5 minutes and the reaction terminated
by spotting 20 ul of each sample onto phosphocellulose disks. The disks were washed as
for the pKC assay, incorporated radioactivity counted and the activity calculated as
pmol/minute/mg protein.

7. Western Blotting and Analysis
Collagenase-digested thyrocytes isolated from thyroid tissues were obtained free of
contaminating lymphocytes as described in Primary Cell Culture (A. 7) above. Thyrocytes
were washed twice with ice cold PBS and extracted with 0.5 ml lysis buffer (1 mM EGTA,
2 mM EDTA, 0.5 mM benzamidine, 5 mM mercaptoethanol, 0.5 mM PMSF and
10 mg/ml leupeptin) (151). Cell suspensions were sonicated (at power setting three) for 30
seconds, then centrifuged at 500 X g for 10 minutes to remove nuclear material. The
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lysates were stored on ice and then dissolved in 250 ul of 0.3% Triton-X-100 lysis buffer.
Total protein was determined by the method of Bradford (148). Ten micrograms of total
protein was loaded per lane on a 12% polyacrylamide Tris-HCl gel (Bio-Rad Laboratories,
Richmond, CA), proteins separated by electrophoresis (152), and electrophoretically-blotted
to nitrocellulose at 100 volts for one hour in 25 mM Tris-HCl, pH 8.3, 192 mM glycine
and 20% methanol. Prestained molecular weight markers (Bio-Rad Laboratories,
Richmond, CA) were electrophoresed in parallel on each gel. Immunodetection was
performed by blocking non-specific binding sites with TBS blocking buffer
(3% dry milk, 0.5% Tween 20 in Tris-buffered saline) for 30 minutes at room temperature.
The membranes were incubated overnight at 4° C with primary antibodies against PKC
isozymes a, (3, y, 5, s, i, 0 and X at a dilution of 1:250 in blocking buffer. The membranes
were washed 5 times for 30 minutes each in TBS buffer, then incubated with secondary
antibody, alkaline phosphatase-conjugated goat antimouse IgG for 1 hour at a dilution of
1:2000 in blocking buffer. Color development was achieved using alkaline phosphatase
substrate BCIP and NBT in a kit (Pierce, Rockford, IL). Controls included (a) a cell
extract provided by Transduction Laboratories and (b) secondary antibody alone. Band
densities were quantified by densitometric analysis.
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8. Microinjection of Cultured Thyroid Cells
The electrophysiologic measurements were performed as previously described in
Microinjection of Cultured Thyroid Cells (A. 9) above.

9. Statistics
As previously described in Statistics (A. 10) above, for the dye transfer studies.
Protein kinase activities and isoenzyme levels were expressed as group means ±_ standard
deviation (SD). Student's Y test was used to determine significant differences between
EAT and control rats for pKA, pKC activities and pKC isozyme levels in thyrocytes
isolated from thyroid tissue.

C. PHASE 3: Enhanced TSH Receptor Expression and Increased Metabolic
Activity in Experimentally Induced Autoimmune Thyroid Disease.
These are methods and materials used to conduct studies in phase 3.
1. Enzyme-linked Immunosorbent Assay for Tg Production in Cell Culture
Supernatants
Supernatants from primary thyrocyte cultures were screened for Tg using a solid phase
ELISA that we developed. This ELISA is similar to that described in Enzyme-Linked
Immunosorbent Assay for the Detection of Anti-Thyroglobulin Antibodies in Serum (A. 4. iv)
with equivalent incubation and washing steps between each antibody. However the antibodies,
order in which they were added and the controls have changed.
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The plates were coated with rabbit anti-human Tg antisera in coating buffer
[(2 ug/well, determined by the estimate of 10 mg of immunoglobulin per ml of immune
sera) (Biomeda, Foster city, CA)]. A starting dilution of 1:50 in PBS was used for all sera.
followed by two-fold serial dilutions. Bovine Tg at a concentration of 50 ng/well (Sigma,
St. Louis, MO) and FRL culture supernatant were the positive and negative controls.
respectively. Rat anti-Tg antisera (1:1000 dilution) obtained from EAT rats was added to
all but 4 control wells. The last antibody added was peroxidase-conjugated goat anti-rat
or human IgG antibody. Color development with HRP substrate was read at an optical
density of 620nm.

2. Quantitation of Metabolic Activity in Viable Cells.
Preceding the measurements of Tg in culture supernatants we determined the
number of viable cells by performing metabolic assays. The assay quantitates the
mitochondrial activity of the cells and is a measure of cell viability in the cultures. A kit
was purchased from Sigma (St. Louis, MO), and includes a tetrazolium compound (MTS)
which when mixed with a coupling agent (PMS) is bioreduced by living cells into
formazan which is soluble in culture medium. This is accomplished by dehydrogenase
enzymes found in metabolically active cells. The freshly prepared solution of MTS and
PMS (mixed in a ratio of 1:20) was added (1:5) to warm Hanks Balanced Salt media.
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100,000 freshly digested cells were added to 480 ul of the PMS-MTS-media
mixture that was 2 fold serially diluted 5 fold in siliconized epitubes, gassed and incubated
at 37° C for 1-1.5 hours. The tubes were then centrifuged at 2,000 rpm for 5 minutes and
the supernatants aliquoted in 100 ul amounts titers into a 96 well microtiter assay plate to
measure the optical density of formazan at a wavelength of 492 nm. Each serial dilution
was measured in duplicate.
The amount of formazan is directly proportional to the number of living cells
converting it. If readings are not adequate, reincubation and remeasuring is possible. The
absorbance was plotted against the number of cells. The assay was performed on both
normal and diseased cells.

3. cAMP Extraction
Tissue was digested into single cells as described in Primary Tissue Culture (A. 7)
divided into 1,000,000 cells per sample and placed in BSA-coated tubes to prevent cell loss by
adherence to the tube wall. Cells were incubated with Forskolin or TSH in one ml of
1% BCS lx PS 5H Dmem:F12 media at 37° C (Gibco, Brl, Grand Island, NY) and rinsed in
warm PBS. One ml of cold 65% ethanol was added to each sample to extract cAMP and a
20 ul aliquot of cell lysate was measured for protein concentration (148). The lysate was
centrifuged at 12,000 X g for 5 minutes to remove cellular debris and the supernatant speed
vacuumed to dryness for stability as described in the cAMP kit (Boehringer Mannheim,
Indianapolis, IN) and stored at 70° C.
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To measure cAMP a competetive ELISA designed as a sandwich assay was used. It
involves a primary, secondary and tertiary antibody linked to an enzyme that digests horse
radish peroxidase (HRP) substrate resulting in a colored product read optically at a wavelength
of 620 nm. Briefly it requires a 96 well microtiter plate coated with cAMP-protein conjugate
that was incubated with samples (7-cAMP). The primary antibody and secondary antibodies
were: primary anti-cAMP IgG and anti-IgG HRP-conjugate. Only the bound IgG was
measured by the secondary antibody. Controls were titrated dilutions of cAMP
(positive control) and secondary HRP-conjugate antibody (negative control). The absorbance
values of the titrated cAMP controls were plotted against the known concentrations of cAMP.
The standard curve was used to extrapolate cAMP values for the treated samples.

4. Flow Cytometric Assessment of TSH Receptor on Rat Thyrocytes
Thyroid cell digests from control and experimental rat thyroid tissue were obtained
as described in Primary Tissue Culture (A. 7). However, the supernatant obtained by
gravity sedimentation was not discarded but labeled for B and T lymphocytes. To obtain
single cells, the thyrocyte-enriched portion was passed through a 200 um mesh screen and
rinsed in cold HBSS.
The thyrocyte and lymphocyte pellets were each divided into test and control samples.
Controls received either the primary or secondary antibodies. Cell samples were each
suspended in 200 ul cold 0.2% BCS IX PS HBSS in sterile siliconized epitubes and incubated
at 4° C, mixing with primary antibody for 30 minutes in 5% C02. The primary antibody for
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thyrocytes was thyroid stimulating immunoglobulins (TSI) from serum of Grave's patients
which binds TSH receptor. For lymphocytes, mouse anti-rat alpha/beta TCR primary antibody
was used (Caltag Laboratories, San Francisco, CA). TSI was a pool of sera often patients
with Grave's disease. The Ig fraction was concentrated by ammonium sulfate precipitation.
The antibody was removed by washing in one ml cold 0.2% BCS IxPS HBSS three
times before incubation with the secondary antibody; affinity purified goat anti-human
FITC-conjugated for thyrocytes and affinity purified goat anti- mouse FITC-conjugated for
lymphocytes. The secondary antibody was incubated for 30 minutes with continuous mixing in
optimum conditions (4° C, 5% C02 and darkness). The secondary antibody was removed by
washing, and the cells were resuspended in 300 ul paraformaldehyde in cold HBSS, stored
overnight at 4° C in darkness and analyzed by flow cytometry.

5. Statistics
As previously described in Statistics (A. 10) above. Tg and cAMP were expressed
as group means +. standard deviation (SD) and significant differences determined by
Student's 'f test between EAT and control rat thyrocyte culture supernatants and isolated
cells from thyroid tissue. TSHr density was analyzed by Kolmogorov-Smirnov statistics.
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D. PHASE 4: Gap Junctional Communication in Fisher Rat Thyroid Cells;
The Absence of Connexin 43 and The Role of Connexin 32 in
Follicle Formation.
These are methods and materials used to conduct studies in phase 4.
1.

Cultured Cell Lines
FRTL-5 cells (ATCC CRL 8305) (22) were maintained in DMEM:Hams F-12

(50:50 v/v) supplemented with 5% calf serum and NTH 6 hormone mix (Thyroid Medium)
(Ambesi-Impiombato et. al., 1980) (22) (somatostatin 10 ng/ml, insulin 10 ug/ml.
hydrocortisone 10 nM, transferrin 5 ug/ml, Gly-Lys-His 10 ng/ml and bovine thyroid
stimulating hormone 10 mli/ml) (Sigma, St. Louis, MO and CalBiochem, San Diego,
CA). FRTL-5 cells were replated by trypsinization at a ratio of 1:3 approximately every
seven days.
FRL cells, a cell line derived from class II pneumocytes, were maintained in
DMEM supplemented with 10% fetal calf serum (Gemini, Calabasas, CA). These cells
were replated by trypsinization every four days. Both cell lines were maintained in 5%
C02:air at 37° C without antibiotics and harvested at 80-90% confluence. Precautions
were taken to test FRTL-5 cells only replated 6-10 times as cells can become “selected”
for abnormalities during prolonged cell culturing.
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2. Enzyme-linked Immunosorbent Assay for Tg Production in Cell Culture
Supernatants
Supernatants from FRTL-5 cultures were screened for Tg using a solid phase ELISA
as described in Enzyme-linked Immunosorbent Assay for Tg Production in Cell culture
Supernatants (C. 1) above.

3. Immunocytochemistry on Cultured FRTL-5 Cells
The cultured cells present on 12 x!2 mm coverslips were fixed and incubated as
described in Immunocytochemistry on Fresh Tissue Sections (A. 5) above wherein
Connexin 43, Connexin 32 and Connexin 26 were localized. FRL cells were used as a
negative control.

4. Immunocytochemistry on Cryosections of Cultured Follicles
FRTL-5 cells were grown in a culture, harvested and the pellet immediately cryopreserved and
sectioned. Connexin proteins 43, 32 and 26 were localized as described in
Immunocytochemistry on Fresh Tissue Sections (A. 5) above.

5. Molecular Biology
RNA was extracted, probed with cDNAs and analysed on a northern blot as described
in Molecular Biology (A. 6) above. One control was similar; rat heart (lane 7). However, the
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other controls were different and included FRL cells (lane 1), rat liver (lane 2), rat thyroid
(lane 6).

6. Microinjection of Cultured FRTL-5 Cells
The electrophysiologic measurements were done as previously described in
Microinjection of Cultured Thyroid Cells (A. 9) above.

7. Statistics
Dye transfer was analyzed as previously described in Statistics (A. 10) above. Tg
expressed as group means ±_ standard deviation (SD) and significant differences determined
by Student's 'f test between EAT and control rat thyrocyte culture supernatants and isolated
cells from thyroid tissue.

8. Karyotyping
Cultured FRTL-5 cells were karyotyped as described by T. C. Hsu (123). The cells
were harvested, fixed in methyl alcohol and glacial acetic acid (3:1) three times, placed on
slides and stained for analysis.

CHAPTER THREE
RESULTS

A. PHASE 1: Characterization of Disease and Reduced Cell-Cell
Conununication in Experimentally Induced Autoimmune Thyroiditis.
Animal models that mimic human disease are used to improve our
understanding of the disease process and hopefully allow the development of alternative
therapies. We induced AT in Lewis rats to develop a model for the study of this
disease. The first objective of this study was to evaluate the extent of induced
autoimmune disease in Lewis rats. The data presented here documents four
characteristics of autoimmune disease in our rats: 1) hypothyroid features [reduced
serum levels of thyroxine, increased levels of TSH; 2) the presence of high concentrations
of circulating anti-thyroid auto-Ab; 3) expression of MHC class II surface antigens; and.
4) morphologic changes that were not detectable in age-matched non-diseased Lewis rats.
The findings demonstrate that the Lewis rat is a suitable model for the study of classical
Hashimoto’s AT.
The second objective of this study was to evaluate the contribution of the target
tissue to the autoimmune disease process. We know that classical Hashimoto’s AT presents
with inflammation-induced extensive interstitial lymphocytic T-cell infiltration and
lymphoid follicle centers composed of polyclonal B-cells. This chronic disease eventually
causes connective tissue and fibrotic changes, with near complete replacement of the thyroid

59

60

epithelium (reviewed in 153). The maintenance of critical physiologic cellular processes is
linked to the integrity of the extracellular environment and influenced by changes in
physical contact between cells (16,53,55). This integration of contiguous cells into an
organized tissue involves many processes, including contact-dependent intercellular
communication. Currently there is little information regarding cell-cell communication
among cells residing in disrupted environments, such as that present in autoimmune
thyroiditis. The changes in tissue organization that accompany inflammation suggested to
us that gap junctions and communication properties would be disrupted by the disease
process. Our premise is that inflammation-induced physical disruption can reduce gap
junctional communication and thereby contribute to the disease process in AT.
The rat model was used to evaluate our premise and ascertain whether induced
autoimmune diseased thyroid tissue had altered gap junctional communication.
Connexin protein, connexin mRNA, and gap junction location were examined in thyroid
tissue from Lewis rats with induced autoimmune thyroiditis and from non-diseased Lewis
rats. Functional differences in cell-cell communication as well as connexin expression were
then assessed in primary thyrocytes established from normal and diseased animals.
The characterization of EAT was commenced with a serological analysis.
1. Serological Findings
Free T4 was 32% lower (1.50 versus 2.20 ng/ml, p< 0.01) and TSH 44%
higher (0.32 versus 0.18 lU/ml, p< 0.05) in the serum from diseased rats. The titers
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of anti-Tg and anti-TPO were more than 10 fold higher in the diseased rats (mean
anti-Tg 824 versus 78 U, p< 0.001; and mean anti-TPO 632 versus 45 IU, p< 0.001)
Table 1. p values were determined using a Student’s't' test.
To determine the potential Tg cross reactivity of the anti-TPO auto-antibodies,
we incubated a 1:25 dilution of rat sera with 1 mg/ml Tg prior to repeating the TPO
ELISA. The titrated values of diseased rat sera were not reduced by this Tg blocking
step (data not shown). Therefore, the IgG class anti-TPO antibodies were not cross
reacting with Tg.

2. Comparative Histology of Thyroid Tissue
As physical disruption of the thyroid tissue by inflammation may be important to the
interpretation of the results of this study we examined the extent of lymphocytic infiltration.
The fixed sections from non-diseased rat thyroids had essentially no detectable
infiltrating cells (Figure 5, panel a). In contrast, the diseased thyroid tissue showed
extensive interstitially distributed mononuclear cells (Figure 5, panel b).
Approximately 30-40% of the thyroid tissue was occupied by infiltrating cells. This
has been previously designated moderately severe or +3 thyroiditis (154). In
harvesting thyroid tissue from rats that had not received a complete immunization
protocol we found significantly less infiltration. There were fewer lymphoid follicle
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Table 1.

Serological Findings of Lewis Rat Examined in This Study.

Subjects
Normal Rats
1 N1
1 N2
1 N3
1 N4
1 N5
2N6
2N7
2N8
2 N9
3 N10
3 Nil
3 N12
Mean6
Diseased Rats
1 D1
1 D2
1 D3
1 D4
1 D5
2 D6
2D7
2D8
3D9
3 D10
3 Dll
Mean6

FreeT4a
2.02
2.08
2.05*
1.84
1.96
2.40*
2.10*
2.74*
2.76
2.32*
2.20*
2.76
2.20+/-.36

1.52
0.95*
1.46
1.05*
1.30*
1.59*
2.33
2.40
1.60*
1.28
1.52*
1.50+/-.55

TSHb
0.22
0.44
0.20
0.14
0.16
0.10*
<.05*
<.05*
0.08
0.15*
0.22*
0.19
0.18+/-.13
0.32
0.34
0.51
0.20*
0.20*
0.20*
0.26
0.60
0.21*
0.35
0.40*
0.32+/-.12

Anti-Tgc

Anti-TPOd
42
56
52
40
36
63
70
46
39
40
38
52

88
100
30
58
175
70
55
91
155
80
71
68
78 + 7-48

1378
1475
663
838
800
780
1042
655
811
850
680
824+7-325

45+7-9

748
493
638
680
638
706
800
625
518
629
714
632 + 7-84

a) Units in ng/dl, sensitivity 0.2ng/dl with a pooled standard deviation of 0.04ng/dl.
b) Values are in :IU/ml (micro-International Units per milliliter), pooled Std. 0.01:IU/ml
c) Values normalized to standard, units equivalent to dilution giving half-maximum (0.5)
optical density.
d) International Units (IU).
e) Mean value plus and minus standard deviation.
*= The sample was undiluted.

Figure 5. Comparative Histology of Thyroid Tissue from Control and Experimental Rats. Fresh frozen thyroid sections
were paraformaldehyde fixed and stained with hematoxylin-eosin. Thyroid tissue from control rats do not show any infiltrating
mononuclear cells (panel a). In contrast, similar sections from experimental rat thyroids revealed extensive interstitially
distributed mononuclear cells indicated by an arrow (panel b). The distribution of T lymphocytes are revealed by fluorescent
antibody localization (panel c). Photographs were taken at 120X magnification.
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centers and the approximate level of infiltration was 20%. These rats had 30% less
anti-TPO autoantibody in their serum, compared to rats that had received the complete
injection series.
Immunofluorescent staining of the infiltrate revealed that the mononuclear cells
were a mixture of polyclonal, IgG+ B-lymphocytes and T-lymphocytes. Unfortunately,
the dual fixation and extensive washing procedures required for immunofluorescence,
results in few lymphocytes retained in the tissue sections. Fluorescent localization of
T cells with anti-rat T cell receptor antibodies (Figure 5, panel c) reveals their
inter-follicular distribution. Small aggregates of B-lymphocytes (lymphoid follicle
centers) were evident in approximately one out of every 15 fields observed (data not
shown). Fibrosis was minimal. Fibrotic changes were present in approximately one in
50 fields examined and was usually associated with small lymphoid follicle centers
adjacent to atrophic thyroid follicles.
In examining autoimmune diseased thyroid tissue slices we found little evidence
of cellular destruction (e.g. minimal amounts of cell debris or liberation of single
thyroid epithelial cells). What was apparent was a loss of follicular organization.
Many follicles were collapsed (atrophic) while others were isolated from contiguous
neighboring follicles by infiltrating lymphocytes.
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3. Immunocytochemical Detection of MHC Class II Expression in Diseased and
Non-diseased Thyroid Tissue
A consistent finding in tissue from inflammatory sites is that MHC class II
expression is abnormal (I). In an effort to determine this in the Lewis rat model the
expression of MHC class II was examined. Thyroid tissue sections obtained from
control and experimental rats were immunolabeled with anti-MHC class II antibodies.
The non-diseased rat thyroid cells had very low levels of immunofluorescent labeling
(Figure 6, panel a) which was equivalent to the negative control (panel c). Thus
normal thyroid tissue did not express MHC class II surface antigens. In contrast, the
diseased rat thyroid tissue showed positive fluorescent localization (panel b). Some
areas showed an uneven distribution of fluorescence suggesting that it might be
enhanced in areas where lymphocytes or lymphoid follicle centers had been located.

4. Immunocytochemical Detection of Connexin Protein Expression in Diseased
and Non-diseased Thyroid Cryosections
Connexin protein expression and distribution were assessed in fresh thyroid
tissue cryosections to determine if the diseased rat thyroid tissue had altered connexin
expression. Figure 7 depicts non-diseased (top panel) and diseased (bottom panel)
thyroid tissue. Thyroid tissue was positive for three connexin-proteins. In the normal
tissue, the primary antisera binding was visualized as punctate fluorescence,
corresponding to aggregates of connexin channels in the form of gap junctional
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Figure 6. Immunocytochemical Detection of MHC Class II Expression in Diseased and Non-diseased Thyroid Tissue.
Thyroid cryosections from Non-Diseased (panel a) and Diseased Rats (panel b) were fixed and incubated with murine
monoclonal anti-rat MHC class II antigen and goat anti-mouse IgG secondary antibody. In the non-diseased thyroid tissue,
there is a low level of immunofluorescence nearly equivalent to the negative control (panel c). This indicates that normal rat
thyroid follicular epithelium does not express MHC class II proteins. The diseased thyroid tissue shows a generally higher level
of fluorescence with a few areas more intensely labeled, demonstrating an increase in MHC class II expression in the diseased
thyroid tissue. Magnification 400X.
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Figure 7. Immunocytochemical Localization of Connexin Protein in Lewis Rat Thyroid Cryosections. Thyroid
cryosections from Non-Diseased (a,b,c) and Diseased Rats (d,e,f) were fixed and incubated with rabbit polyclonal antisera
specific for Connexin43 (a & d), Connexin32 (b & e) and Connexin26 (c & f). In the non-diseased thyroid tissue, the majority
of discrete punctate fluorescence, corresponding to aggregates of connexin protein assembled into gap junctional plaques, is
localized at points of membrane contact between adjacent cells in the tissue. Conversely, the diseased tissue is significantly
reduced in fluorescent intensity and the gap junctions are not localized at points of cell contact. Cell to cell contact regions are
indicated by arrows, and for reference one cross-sectioned thyroid follicular lumen in each image is marked with an asterisk.
Magnification 400X.
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plaques. The discrete punctate fluorescence corresponding to aggregates of
Connexin 43 was located on the outer membrane of thyroid follicular cells (panel a).
Connexin 32 in the tissue was more prominent than Connexin 43 and the
Connexin 32-junctional plaques occurred between cells in the same follicle (lateral to
the follicular lumen) (panel b). Connexin 26 gap junctional plaques were primarily
localized at or near the lumenal surface (panel c). In the diseased rat thyroid tissue the
fluorescent intensity for all three connexin-proteins was reduced, and gap junctions
were absent from the plasma membrane (panels d,e,f).

5. Northern Analysis for Connexin mRNA
Total RNA was extracted and hybridized with connexin-specific cDNAs to
determine if the reduced connexin protein detected in the diseased tissue was coincident
with lower connexin transcripts. The amount of total RNA loaded for the diseased and
non-diseased thyroid tissue was densitometrically equivalent. The results shown in
Figure 8 revealed that the hybridization signal from the diseased rat RNA was lower
for all three connexins. Connexin 43 was reduced to the greatest extent (45 %)
followed by Connexin 26 (25%) and then Connexin 32 (20%). The results from three
separate experiments varied by approximately V- 5 % of the values depicted in
Figure 8.
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Figure 8. Northern Analysis for Connexin Expression in Lewis Rat Thyroid
Tissue. Shown are the results of hybridization of three northern blots containing total
RNA from; rat heart (lane 1), mouse liver (lane 2), Non-diseased rat thyroid (lane 3)
and diseased rat thyroid (lane 4). The blots were hybridized with connexin-specific
cDNAs indicated. Ribosomal bands are marked with arrows.
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6. Immunocytochemical Detection of Thyroglobulin Protein in Cultured
Thyrocytes
Prior to immunocytochemistry for connexin protein expression and
micro injection studies, cultured thyroid cells were tested for Tg content. Greater than
98% of the established cells and thyroid tissue sections were thyrocytes as they labeled
positive with polyclonal anti-Tg antisera (Figure 9, panels a and b). The controls did
not immunostain for Tg (panel c). The results of immuno-staining for lymphocytes in
these cultures were negative (data not shown).

7. Immunocytochemical Detection of Connexin Protein in Cultured Thyrocytes
These cultures were then tested for immuno-reactive connexin protein to
determine whether the cells isolated from the diseased rats had altered connexin/gap
junctional assembly as we had seen in the tissue sections. The cultured normal thyroid
cells produced all 3 connexins. Connexin 43 was the most prominent in the
monolayers followed by Connexin 26 and lastly Connexin 32. Connexin 32 increases
with follicle formation. The cultured cells from the diseased thyroids displayed the
same order of preferential expression, although with reduced fluorescent intensity
corresponding to reduced relative levels of all three connexins. In addition the diseased
thyroid epithelial cultures tendency to form fewer follicles resulted in further reduced
amounts of Connexin 32.
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Figure 9. Immunocytochemical Labeling of Thyroglobulin in Cultured Thyroid Cells. Absolute ethanol fixed 5 day
thyroid cultures were labeled with rabbit polyclonal anti-human Tg and fluorescein-conjugated goat anti-rabbit IgG secondary
antibody. Control rat (panel a) and Experimental rat (panel b) thyroid cells label positive for Tg. The Tg was localized to the
cytoplasm of the epithelial cells. However this binding of anti-Tg was not evident in the control sections that were incubated
with non-immune rabbit sera and fluorescent secondary antibody (panel c). The magnification is approximately 400X.
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The most striking difference between the diseased and non-diseased thyroid cell
cultures was the location of connexin-specific immunofluorescence. This differential
localization is best depicted using Connexin 43 labeled cultures. The non-diseased
thyroid cells (Figure 10, panel a) reveals a discrete distribution of Connexin 43 in the
plasma membrane at points of cell-cell contact. In the diseased cultures, however, the
anti-Connexin 43 antisera binding was not localized in the plasma membrane but was
evident as discrete aggregates located in the cytoplasmic and perinuclear regions of the
cells (Figure 10, panel b). This indicated that removal of the cells from the
inflammatory environment did not restore the normal (plasma membrane) distribution
of gap junction proteins.

8. Basal State Intercellular Transfer of Lucifer Yellow Dye in Primary Thyrocyte
Cultures
The aberrant location of the gap junctions in the diseased cells presumes a loss
of function. To establish whether this inappropriate connexin distribution was
associated with reduced cell-cell communication, microinjections were done on these
primary thyroid cultures. Non-diseased thyrocyte monolayers (Figure 11, panels a
and b) transferred dye from the injected cell to adjacent cells (primary transfer) in
nearly all trials. Follicular cultures from the control rats were able to transfer dye to
third and fourth order contacting cells in the majority of tr ials (panel d). In contrast,
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Figure 10. Immunocytochemical Detection of Connexin Protein Expression in Thyroid Cultures from Lewis Rats.
Absolute ethanol fixed 5 day thyroid cultures were labeled with rabbit polyclonal anti-Connexin43 antisera and fluoresceinconjugated goat anti-rabbit IgG secondary antibody. Arrows indicate plasma membrane contact between adjacent cells.
Thyrocytes from control rat cells have immuno-fluorescence corresponding to aggregates of Connexin43 protein assembled into
gap junctional plaques in the plasma membrane at points of cell to cell contact (panel a). The thyroid cells from experimental
rats show similar punctate fluorescence but it is not located in the plasma membrane. The diseased cells show cytoplasmic and
perinuclear Connexin43 protein aggregates (panel b). Non-immune rabbit sera and fluorescent secondary antibody controls are
identical to that shown in Figure 9. The magnification is approximately 630X.
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Figure 11. Basal State Intercellular Transfer of Lucifer Yellow Dye In Primary
Thyrocytes From lewis rats. The composite is arranged with the phase images
(panels a,c,e) next to their corresponding fluorescent images (b, d, f). The phase
images indicate the extent of membrane contacts not evident from the fluorescent
image alone. Thyrocyte monolayers from normal rats (a, b), cultured follicle from
normal rats (c, d) and monolayer thyrocytes from diseased rats (e, f). Injected cells are
indicated by an arrow. Collectively the microinjection experiments performed on
representative 5 day cultures show that diseased thyrocytes do not transfer dye to
contiguous neighboring cells, whereas, microinjection of dye into control rat
monolayers and follicles resulted in dye transfer to at least secondary contacting cells
(see Table 2 for details of dye transfer). Magnification 630X.
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the diseased thyroid cultures, failed to transfer fluorescent dye to any directly
contacting cells in >90% of trials (n=100) (panels e,f). The number and size of
follicles in the cell cultures from diseased rats were reduced. Even the cells within
diseased rat follicles did not transfer dye. The composite results from the experiments
are given in Table 2.

Table 2. Intercellular Dye Transfer In Primary Thyrocytes From Experimental
Autoimmune Diseased and Non-Diseased Rats.

Degree of Dye
Transfer51

(% of Trials*)
Non-Diseased
(Monolayer)b
(Follicle)6

Diseased
(monolayer)d
(Follicle)6
90
95

0°

2

0

1°

98

100

10

5

2° & 3°

80

95

0

0

a) 0° = No dye transfer, 1° = Dye transfer from the injected cell to cells in direct
contact and 2° & 3° = Dye transfer from the injected cell to peripheral cells not in
direct contact, but separated by one and two intervening cells, respectively.
b) Percentage based on 160 Injections from 8 different cultures tested between days 3-7.
c) Percentage based on 120 Injections from 8 different cultures tested between days 3-7.
d) Percentage based on 100 injections from 5 different cultures tested between days 3-7.
e) Percentage based on 30 injections from 3 different cultures tested between days 3-10.
*) Dye transfer images were captured at one and two minutes after injection, percentage
calculations were made from the extent of dye transfer at two minutes.
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B. PHASE 2: Elevated levels of Protein Kinase C Isozymes in Experimental
Autoimmune Thyroiditis Prevent the Assembly of Connexin 43 Gap Junctions
and Reduce Intercellular Communication.
We have reported that thyroid tissue and cultured thyrocytes obtained from Lewis
rats with induced AT are comparatively communication-deficient, as indicated by deficient
connexin protein expression (Connexins 43, 32 and 26), inability to assemble connexin
protein into gap junctional plaques in plasma membranes and transfer dye from one
contacting cell to another (phase 1) (35). Despite efforts to eliminate cellular disruption
(by removing inflammatory mediators and infiltrating lymphocytes), and maximize cell to
cell contact in thyrocytes by culturing these cells, loss of cell-cell communication and
membrane-associated connexin plaques persisted. This suggests that mechanisms other than
physical disruption are responsible for the sustained uncoupling observed in AT.
Connexin 43 is the predominant connexin found in monolayers of thyrocytes
(21,35). Connexin 43 is a phosphoprotein that is positively affected by
cAMP-dependent protein kinase A (pKA) activity in a number of transformed (91) and
primary cell types (37,96,97). In contrast, negative regulatory effects have been attributed
to protein kinase C (pKC) activity (98). Phorbol esters e.g. TPA, and more physiologic
activators e.g. OAG (an analog of diacyl glycerol) increase pKC activity and concomitantly
decrease Connexin 43-mediated intercellular communication (99-101). Under conditions of
sustained, elevated pKC activity, Connexin43 protein aggregates locate to cytosol and
perinuclear regions of the cells instead of in the plasma membrane at contacting cell
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interfaces (101). This abnormal localization of connexins can account for the loss of
intercellular dye transfer.
The predominance of Connexin 43 in monolayer thyroid cultures, and the regulation of
this connexin by phoshorylation led us to investigate pKA and pKC activities in the diseased
thyroid relative to non-diseased thyroid tissue/cells. The current study explores whether there
are differences in basal protein kinase activity between autoimmune-diseased and
non-diseased thyroid cells that can account for their abnormal gap junctional assembly and
reduced intercellular communication. We identified a number of pKC isozymes and
measured their protein levels in tissues and cultured thyrocytes from EAT and non-disease
rats. Lastly, and most importantly, in an effort to determine if the relationship between
protein kinase activities and communication deficiency is causal or associative, we
experimentally modulated pKC activity in cultured thyrocytes from control and EAT rats
using OAG (stimulation) and Calphostin C (inhibition). Following treatments, we
measured changes in Connexin 43 gap junctional plaques in the plasma membrane at points
of cell to cell contact, and the ability of microinjected cells to transfer fluorescent dye to
contiguous cells in the monolayer.
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1. Pathology and Serology of EAT in Lewis Rats
The autoimmune-diseased thyroid tissues and thyroid cells analyzed in the current
study were obtained from EAT Lewis rats showing the hallmarks of autoimmune thyroiditis.
The following pathology and serology have been previously described in Comparative
Histology of Thyroid Tissue (Chapter 3, A. 2).

2. Elevated Basal pKC Activity and Normal pKA Activity in Thyroid Tissue from
EAT Rats
pKA and pKC activities were measured in thyrocytes isolated from thyroid tissues
of EAT and control rats. The data from duplicate studies which included a minimum of 5
replicates within a study group were pooled for analysis of group means +/_ SD and
determination of statistical significance by Student's 'f test (Table 3). Autoimmune thyroid
disease did not significantly (p > 0.05) alter the basal pKA activity of thyrocytes (average
control of 27 7_ 3 pm/min/mg-protein versus an average experimental of 28.5 7_ 4)
(Table 3). However, basal pKC activity in the experimentally induced rats (average of
49 7_ 6 pmol/min/mg protein, n= 15) was significantly higher (p < 0.001) than the basal
pKC activity in the control rat thyrocytes (average of 27.5 7- 3 pmol/min/mg-protein,
n= 14) (Table 3).
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Table 3. Protein Kinase A and Protein Kinase C Activities in Thyrocytes
pmol/min/mg protein)

Study

pKA Activity

pKC Activity

(Mean + /- SD)

Mean +/- SD)

Control

EAT

Control

EAT

1

26 7_ 2 (n = 8)

28 7_ 4 (n = 8)

27 7_ 3 (n = 6)

47 V- 2 (n = 12)

2

28 7_-3 (n = 6)

29 7-4 (n = 6)

28 7-2 (n =8)

51 7- 3 (n = 7)

The numbers of animals (n) for which thyrocyte protein kinase activities were measured are
indicated for each treatment group. Student's Y test of the pooled data from studies 1 and
2 determined that pKA activity did not significantly differ between control and EAT
thyrocytes (p> 0.05); however, pKC activity was significantly different between these two
groups (p< 0.001).

3. Differential Expression of Specific pKC Isozymes in Thyroid Tissue from EAT
Rats
Comparison of immunocytochemically-labeled pKC isozymes alpha, beta, delta,
and epsilon in thyroid cryosections from EAT and control rats (Figure 12) provided
qualitative evidence that specific pKC isozymes are elevated in thyroid tissue in the
autoimmune disease state. Western blot analyses quantified the relative levels of specific
pKC isozyme proteins in thyrocytes isolated from thyroid tissue of EAT and control rats
(representative blots, Figure 13). Mean % increases 7_SD were calculated for five
replicate experiments. The following significant increases (p< 0.001) above basal
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Figure 12. Qualitative Comparison of Immunoreactive pKC Isozyme Levels in
Thyroid Tissue from EAT and Control Rats. Thyroid cryosections from control (panels
a, c, e, and g) and EAT (panels b, d, f, and h) rats were immunolabeled with monoclonal
antibodies specific for each pKC isozyme and fluorescein conjugated secondary antibody.
EAT rats expressed higher levels of these pKC isozymes in their thyroid tissue than control
rats: pKC alpha (panel b versus a), pKC beta (panel d versus c), pKC delta (panel f versus
e), and pKC epsilon (panel h versus g).
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Figure 13. Quantitative comparison of pKC isozyme protein expression in EAT and
control rat thyroid by Western blot analyses. Panels: a, alpha; b, beta; c, gamma; d,
delta; e, epsilon; f, iota; g, lambda; and h, theta. Equivalent amounts of protein from
control and EAT rat thyroid tissue were electrophoresed, transferred to nitrocellulose and
hybridized with murine monoclonal antibodies specific for 8 pKC isozymes. Goat
antimouse alkaline phosphatase conjugated secondary antibody binding was quantitated by
densitometry. Molecular weight standards were run in parallel and the corresponding lane
indicated with an M. The positive control cell lysate lane is marked with a C, thyroid tissue
from non-diseased rats is indicated by an N and thyroid tissue lysate from diseased rats with
a D. The appropriate migration distance for each isozyme is indicated (arrows).
Thyrocytes from EAT rats expressed higher levels of PKC isozymes alpha, beta, delta, and
epsilon, and uniquely expressed gamma and lambda. The autoimmune disease state did not
alter thyrocyte expression of theta, and iota was not detected in thyrocytes from either EAT
or control rats.
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(control rat) levels were observed in thyrocytes from EAT rats: pKC alpha (40% 7_ 3,
Figure 13, panel a), beta (30% 7_ 4, Figure 13, panel, b), delta (31% 7_ 4, Figure 13,
panel d), and epsilon (25% 7_ 2, Figure 13, panel e). Expression of pKC gamma
(Figure 13 panel c) and lambda (Figure 13, panel g) were detected in thyrocytes from EAT
rats but not control rats. There was no difference in the amount of pKC theta in thyrocytes
from EAT and control rats (Figure 13, panel h). Lastly, pKC iota was not detected in
tissue from either EAT or control rats (Figure 13, panel f)-

4. Modulation of pKC Activity in Cultured Thyrocyte Monolayers Alters
Connexin 43-Mediated Intercellular Communication
Does pharmacologic stimulation of pKC activity in normal thyrocyte monolayers
cultured from control rats produce a deficit in Connexin 43-mediated intercellular
communication? Dye transfer between normal thyrocytes in monolayers was measured in
the presence and absence of OAG, an analog of diacyl glycerol which stimulates pKC
activity (Figure 14). Dye transfer between the cell microinjected with fluorescent dye and
contacting neighboring cells is a functional measure of intercellular communication.
Untreated normal thyrocyte monolayers transfer dye to primary, secondary and tertiary
contacting cells (Figure 14, panel b) in 98%, 80% and 70% of trials (Table 4). A three
hour incubation with 10 uM OAG blocked the transfer of dye from injected cell to primary
contacting neighboring cells (Figure 14, panel d) in 80% of trials (Table 4). Up-regulation
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Figure 14. Intercellular communication in cultured thyrocytes from normal rats
following in vitro treatment to increase cellular pKC activity, a and b, untreated,
normal (control rat) thyrocytes. Panels c and d, normal (control rat) thyrocytes incubated
with 10 uM OAG for 3 hours to increase pKC activity. Panels a and c, phase images to
indicate extent of cell to cell contact in the monolayer. Panels b and d, fluorescent images
of intercellular dye transfer. Magnification 630X. The untreated cells transfer lucifer
yellow dye to contacting neighboring cells, whereas, OAG treatment prevents the cells from
transferring dye to cells in direct contact. Images are representative of 100 replicate dye
transfer assays per treatment group; the change in dye transfer is highly significant by Chisquare analysis (see Table 4).
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Table 4. The effect of modulating pKC activity on intercellular dye transfer in
primary thyrocytes from Experimental Autoimmune Thyroiditis;
diseased cells treated with Calphostin C and non-diseased cells treated with
OAG

Degree of Dye
Transfer

0°

(% of Trials*)
Non-Diseased
OAG
Treated1*
Control6
80
20

Diseased
Cal-C
Treated*1
5

Control6
90

1°

20

98

95

10

2°& 3°

0

80

75

0

a) 0° = No dye transfer, 1° = Dye transfer from the injected cell to cells in direct
contact and 2° & 3° — Dye transfer from the injected cell to peripheral cells not in
direct contact, but separated by one or two intervening cells, respectively.
b) Treated with OAG (10 uM) and based on 20 injections from 3 different cultures tested
between days 3-7.
c) Control, untreated monolayer of thyrocytes. Percentage based on 120 injections from 8
different cultures tested between days 3-7.
d) Treated with Calphostin C (100 nM) for 4 hours. Percentage based on 20 injections
from 3 different cultures tested between days 3-7.
e) Not treated. Percentage based on 30 injections from 3 different cultures tested between
days 3-10.
*) Dye transfer images were captured at one and two minutes after injection, percentage
calculations were made from the extent of dye transfer at two minutes.
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of pKC activity by OAG produced a highly significant decrease in functional intercellular
communication (p< 1 X 10'11, Chi-square analysis). Localization of Connexin 43 gap
junctions was visualized by immunofluorescent labeling of Connexin 43 protein in the
thyrocyte monolayers (Figure 15). Untreated normal thyroid epithelial cells showed
numerous discrete fluorescent plaques corresponding to Connexin 43 gap junctions in
plasma membranes at points of cell to cell contact (Figure 15, panel a). Treatment with
OAG caused a reduction in Connexin 43 gap junctions in plasma membranes at points of
cell to cell contact (Figure 15, panel b).
Does pharmacologic inhibition of the elevated pKC activity in thyrocyte
monolayers cultured from EAT rats restore Connexin 43-mediated intercellular
communication? Dye transfer between normal thyrocytes in monolayers was measured in
the presence and absence of Calphostin C, an inhibitor of pKC activity (Figure 16).
Intercellular communication was restored in Calphostin C-treated EAT thyrocyte
monolayers (Figure 16, panel d) as compared to untreated EAT thyrocyte monolayers
(Figure 16, panel b) which were unable to transfer microinjected fluorescent dye. The
degree of dye transfer was either primary (98%) or secondary and greater (75 %) in nearly
all the Calphostin C-treated EAT thyrocytes examined (Table 4). Down-regulation of pKC
activity by Calphostin C produces a highly significant increase in functional intercellular
communication (p< 1 X 10'13, Chi-square analysis). Localization of Connexin 43 gap
junctions was visualized by immunofluorescent labeling of Connexin 43 protein in the
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Figure 15. Localization of inununoreactive Connexin43 gap junctions in cultured thyrocytes from normal rats following in
vitro treatment to increase cellular pKC activity, a, untreated normal (control rat) thyrocyte monolayer. Panel b, normal (control
rat) thyrocyte monolayer incubated with 10 uM OAG for 3 hr. Normal thyroid cells have numerous Connexin 43 gap junctions at
points of cell to cell contact (arrow) which are absent from contacting cell surfaces following OAG treatment to increase pKC activity.
Magnification 630X. Images are representative of 20 monolayers examined per treatment group.
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Figure 16. Intercellular communication in cultured thyrocytes from EAT rats
following in vitro treatment to decrease pKC activity. Panels a and b, untreated
thyrocyte monolayers from EAT rats. Panels c and d, EAT rat thyrocyte monolayers
incubated with Calphostin C for 4 hours. The injected cells are indicated by arrows.
Panels a and c, phase images indicate the extent of cell to cell contact in the monolayer.
Panels b and d, fluorescent images of intercellular dye transfer. Magnification 630X.
Cultured thyrocytes from EAT rats do not transfer dye to their neighboring cells; however,
when their pKC levels are down-regulated with Calphostin C, the ability to communicate
with adjacent cells is restored. Images are representative of 100 dye transfer assays per
treatment group; the change in dye transfer is highly significant by Chi-square analysis (see
Table 4).
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thyrocyte monolayers (Figure 17). The absence of Connexin 43 gap junctions in the plasma
membranes of thyrocytes from EAT rats persisted under culture conditions which form cell
monolayers (Figure 17, panel a). Treatment of thyrocytes from diseased rats with
Calphostin C to reduce their elevated levels of pKC activity allowed Connexin 43 protein
aggregates to assemble in plasma membranes at points of direct cellular apposition
(Figure 17, panel b).

C. PHASE 3: Enhanced TSH Receptor Expression and Increased Metabolic
Activity in Experimentally Induced Autoimmune Thyroid Disease.
We have established in EAT, that an elevated pKC activity reduces gap junctional
communication that correlates with reduced thyroid function. The deficient
communication is not a direct result of physical separation, or lymphocyte-derived
cytokines (Phase 1), but rather an increase in pKC isozymes and induction of disease
specific isozymes y and X responsible for elevated pKC activity (Phase 2). The elevated
pKC activity reduces the expression and assembly of Connexin 43 gap junctions. PKA
activity is not significantly different in diseased versus non-diseased thyrocytes and
does not appear to contribute to the low T4 abnormality we have measured. The
pKC-mediated reduction of intercellular coordination, we believe, contributes to the
pathogenesis of EAT. The objective of this study was to examine the role of the TSHr
and integrate this with other EAT-specific observations (elaborated below).
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Figure 17. Localization of immunoreactive Connexin 43 gap junctions in cultured thyrocytes from EAT rats following in vitro
treatment to inhibit cellular pKC activity. Panel a, untreated EAT thyrocyte monolayer. Panel b, EAT thyrocyte monolayer
incubated with 100 nM Calphostin C for 4 hours to decrease pKC activity. Magnification 630X. EAT thyrocytes do not exhibit
Connexin 43 gap junctions at points of cell to cell contact in their plasma membranes. Following Calphostin C treatment, the
Connexin 43 aggregates are reassembled into gap junctions at contacting cell surfaces. The images are representative of 20
monolayers examined per treatment group.
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We observed that diseased thyrocytes a) were more rapidly established in
culture, b) had an increased growth rate, c) reached senescence earlier and
d) conditioned the media as determined by color change. We suspected the diseased
thyrocyte cultures were producing increased amounts of Tg which was confirmed by
immunocytochemical staining (Immunocytochemical Detection of Thyroglobulin Protein
in Cultured Thyrocytes Chapter 3, A. 6, Figure 9). These observations suggested the
diseased cells were metabolically more active than non-diseased cells. We assessed Tg
concentrations in culture supernatants and further determined the mitochondrial activity
of isolated thyrocytes.
TSHr can mediate thyroid processes via its link to pKA and/or pKC (116-117).
We examined the TSHr to determine: a) if it was linked under basal conditions to pKA
or PKC, b) if it was functioning and tranducing signals normally, c) if it was
responsible for the elevated pKC activity and d) additionally we determined if the pKA
pathway was functioning normally. This was done by measuring the levels of the
second messenger of this pathway (cAMP) after modulating the pKA pathway and
cAMP levels. To assess these potential associations between TSHr function and surface
expression, and the elevated metabolic activity and/or the elevated pKC activity, we
conducted the studies below.
We assessed the following in diseased and non-diseased thyrocytes: 1) Tg
secretion; 2) metabolic activity; 3) levels of cAMP, the second messenger of the pKA
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pathway at basal, and post-forskolin and TSH modulations; 4) TSHr surface receptor
density by fluorescent flow cytometry.

1.

Comparative Assessment of Thyroglobulin Concentrations in Supernatants
Obtained from Diseased and Non-diseased Rat Thyrocyte Cultures.
The supernatants were obtained from equivalent 5-7 day cultures. Three

separate cultures with six replicate samples/culture were used to obtain these results.
We developed a solid phase ELISA to quantitate the amount of Tg in these
supernatants. The positive and negative controls were bovine Tg and supernatant from
FRL cultures (non-thyroidal cells). Thyroglobulin concentrations were significantly
higher (36%) in supernatants of diseased cultures in comparison to non-diseased
cultures [265.5 7- 5.5 versus 170.5 7_ 4.5 (p< 0.001 in 6 replicates)] as seen in
Figure 18.

2.

Comparative Assessment of the Metabolic Activity of Diseased and Non
diseased Thyrocytes.
Freshly digested thyrocytes were counted and serially diluted. The 50,000 cells

per sample were incubated with a tetrazolium compound to assess the amount of
formazan formed by mitochondrial reduction. The assay determines the number of
viable metabolically active cells in a sample. Precautions were taken to similarly
process the samples, determine the cells were viable using a trypan blue exclusion and
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Figure 18. Comparative Assessment of Thyroglobulin Concentrations in
Supernatants obtained from Diseased and Non-diseased Rat Thyrocyte Cultures.
A sandwich ELISA using antibodies; rabbit anti-human thyroglobulin, bovine
thyroglobulin, peroxidase-labeled goat anti-rat IgG and TMB substrate. Tg was 36%
higher in diseased cells than non-diseased cells (265.5 7-5.5 versus 170.5 7_ 4.5,
p< 0.001) for replicates of six. Similar results were repeated in three experiments.
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conduct the assay in duplicate. The diseased thyrocytes were 33% more metabolically
active than non-diseased thyrocytes [1.25 7-0.05 versus 0.83 7_ 0.06, (p< 0.001 in
6 replicates) (Figure 19)]. Results were duplicated in 6 separate experiments.

3.

Assessment of cAMP Levels in Non-diseased and Diseased Thyrocytes
Freshly digested cells were isolated from lymphocytes, divided into 200,000

cells per sample and analyzed for cAMP levels in triplicate. Samples were incubated
with Forskolin (lOuM) for 3 hours or with TSH (10 mU) for one hour. Preliminary
data compiled from four studies demonstrated cAMP levels were not significantly
different in non-diseased cells when compared to diseased thyrocytes (254 7_ 9 in
12 replicates versus 234 7_ 8, p> 0.05 in 9 replicates (Table 5). Forskolin upregulated
cAMP levels 12.8 fold in non-diseased cells (3176 7_24 in 3 replicates). TSH
upregulated cAMP about 0.2 fold (261 7-6 in 3 replicates) which was much lower than
the potent stimulation of Forskolin that directly activates adenylate cyclase to produce
cAMP. EAT does not appear to change the mechanics of the pKA pathway or how
cAMP activates pKA.
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Figure 19. Comparative Assessment of the Metabolic Activity of Diseased and
Non-diseased Thyrocytes. The metabolic activity of freshly digested cells was
measured at an absorbance of 490 nm (OD) when graphed as OD versus cell density.
Figure 19 demonstrates the metabolic activity in diseased cells was higher than that in
non-diseased cells (1.25 versus 0.83 +/- 0.64, p< 0.001 in 6 replicates). Results were
duplicated in 6 separate experiments.
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Table 5.

Quantitative Comparison of cAMP Levels in Non-diseased and Diseased
Thyrocytes

cAMP (mean 7_ SD)(fmol)
Basal Study

Non-diseased

Diseased

1

243 7_9
n= 6
261 7_8
n= 6

224 7_7
n= 6
244 7_6
n= 3

2

The numbers of samples (n) for which thyrocyte cAMP levels were measured are indicated
for each group. Student's 't' test of the pooled data from studies 1 and 2 determined that
cAMP levels did not significantly differ between non-diseased and diseased thyrocytes
(p >0.05).

4. Separation of Thyrocyte and Lymphocyte Populations in Thyroids as Detected
by Fluorescent Flow Cytometry
Thyroids were collagenase-digested and the majority of contaminating
lymphocytes were removed by gravity sedimentation to obtain a thyrocyte-enriched
pellet for analysis. Based on the differences in size and granularity, we further
separated the cells by side scatter plotting to obtain a population of the larger thyrocytes
with negligible contamination by the smaller lymphocytes. These parameters were
noted. Therefore, the thyrocyte-enriched samples were labeled for thyrocytes and
separately for lymphocytes. Since thyrocytes normally possess TSHr on their surface.
an antibody to TSHr: TSI, obtained from Grave’s patient sera was used to identify the
thyrocytes. Simultaneously, any remaining contaminating lymphocytes were
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immunolabeled with a mixture of phycoerythrine-conjugated mouse anti-rat pan B-cell
marker and mouse anti-rat CD2 (pan T-cell marker).
Two discrete populations of cells were visible by side scatter plotting as large
cells in Gate R1 and small cells in Gate R2 (Figure 20A). The degree of fluorescent
labeling (the extent of the left to right shift from the control curves) is depicted by the
x axis of the histogram while the y axis depicts the number of cells sampled
(Figures 20B and 20C). The percentage of cells that immunolabel (fluorescent label)
are shown in the numbers below the histograms.
To determine the parameters wherein we could analyze thyrocytes
predominantly, we assessed the thyrocyte-enriched sample. We found the Gate R1
population was predominantly thyrocytes (99%) (Figure 20B, panel b) compared to a
1% lymphocyte contamination (Figure 20C, panel b). The lymphocytes that are
detected in Gate R1 (1 %) are negligible and do not stain for TSHr, therefore we used
the Gate R1 for subsequent analysis of thyrocytes.

5. Comparative Assessment of TSH Surface Receptor Expression on Diseased and
Non-diseased Rat Thyrocytes as Detected by Fluorescent Flow Cytometry
Digests of diseased and non-diseased thyroids were treated identically and
labeled with primary antibody, TSI to the TSHr and a fluorescein-conjugated goat anti
human secondary antibody. Controls were cells immuno-labeled with either primary or
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Figure 20. Separation of Thyrocyte and Lymphocyte Populations in Thyroids as
Detected by Fluorescent Flow Cytometry. Samples were labeled for thyrocytes and
lymphocytes. The x axis is the degree of fluorescent labeling and the y axis the
number of cells. Figure 20A depicts the scatter plot of digested cells as two discrete
populations Gate R1 and Gate R2. TSHr was labeled with Thyroid stimulating
immunoglobulin (TSI) and fluorescein-conjugated anti-human IgG secondary antibody.
Lymphocytes were labeled with phycoerythrine-conjugated pan B-cell marker and CD2
(pan T-cell marker). The resulting histograms obtained from separate thyrocyteenriched samples demonstrate 99% of the cells in Gate R1 label positive to TSI. (20B,
panel b) and 1 % of the cells in gate R1 label as lymphocytes (Figure 20C, panel b).
The majority of cells in gate R1 were thyrocytes and was therefore used for all
subsequent analyses of thyrocytes.
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secondary antibodies. Only cells within Gate R1 were assessed to eliminate
interference with contaminating lymphocytes.
A left to right shift on the x axis corresponds to the degree of fluorescent
labeling demonstrating the cells stained for TSHr. Figure 21 shows the left to right
shift in non-diseased thyrocytes (panel a) and in diseased cells (panel b). This
demonstrates that a left to right shift on the x axis indicates an increase in fluorescence.
Therefore TSH receptors were expressed on the cell surfaces. Figure 22 depicts a
combined analysis of non-diseased and diseased thyrocyte populations. Ml showed
99.4% expressed TSHr on their surfaces and were therefore thyrocytes. Seventy
two % of the diseased cells expressed a higher density of TSHr on their surface in
contrast to 45% of non-diseased cells. Therefore, 27% more diseased cells expressed a
higher density of TSHr in comparison to non-diseased cells. This 27% increase was
significant as determined by Kolmogorov-Smirnov statistics with a fluorescence mean of
312 versus 226, p< 0.01 (Figure 22 insert).

6.

Comparative Assessment of Two Populations with High and Low TSH Surface
Receptor Expression on Diseased and Non-diseased Rat Thyrocytes as
Detected by Fluorescent Flow Cytometry
The bimodal peaks observed in Figure 23 (panels a and b) demonstrate that both

the diseased and non-diseased thyrocytes had two populations (Ml and M2). The cells
in the M2 population have a higher receptor density in comparison to the Ml
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Figure 21. Detection of TSH Surface Receptor Expression on Diseased and Nondiseased Rat Thyrocytes as Detected by Fluorescent Flow Cytometry. Freshly
collagenase-digested cells were immunolabeled with antibodies to TSHr (TSI) and
fluorescein-conjugated anti-human IgG secondary antibodies. Fluorescent staining was
determined in cells in gate Rl. The left to right shift on the x axis depicts an increase
in fluorescence above that of the primary or secondary antibodies alone which
demonstrates the fluorescent immunostaining of the TSHr. Panel a shows the nondiseased cells and panel b shows the diseased cells.
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Figure 22. Comparative Assessment of TSH Surface Receptor Expression on Diseased and Non-diseased Rat Thyrocytes
as Detected by Fluorescent Flow Cytometry. Freshly collagenase-digested cells were immunolabeled with antibodies to TSHr
(TSI) and fluorescein-conjugated anti-human IgG secondary antibodies. Fluorescent staining was determined in cells in gate
Rl. The A left to right shift on the x axis depicts positive staining as shown in non-diseased cells (22A panel a) and diseased
cells (22A panel b). Figure 22B shows that more diseased cells (72%) expressed TSHr at a higher density than non-diseased
cells (45%) with a fluorescence mean (312 versus 226, p< 0.01). Results were significant as determined by KolmogorovSmirnov statistics (Figure 22B insert).
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Figure 23. Comparative Assessment of Two Populations with High and Low TSH
Surface Receptor Expression on Diseased and Non-diseased Rat Thyrocytes as
Detected by Fluorescent Flow Cytometry. Samples were labeled for percentage of
thyrocytes and lymphocytes. The x axis depicts the degree of fluorescent labeling and
the y axis the number of cells. TSHr was labeled with Thyroid stimulating
immunoglobulin (TSI) and fluorescein-conjugated anti-human IgG secondary antibody.
The resulting histograms demonstrate there were two separate populations in nondiseased and diseased thyrocytes; one with high expression of TSHr and the other with
low expression of the TSHr. The diseased had 44% more cells with high expression
(72% versus 28%) while the opposite occurred in non-diseased cells where 10% more
cells expressed TSHr at a low density than at a high density (55 % versus 45 %).
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population which expresses TSHr at a lower density. The diseased cells had a
percentage of cells that expressed TSHr at a higher density (72%) and another
percentage of cells with lower TSHr density (28%) i.e. a 44% difference. In contrast.
in non-diseased thyrocytes a reversal occurred with more cells expressing TSHr at a
lower density (55%) than at a higher density (45%) i.e. a 10% difference. The
compiled results are shown in Table 6.

Table 6. Comparative Assessment of the Two Populations Occurring in Both
Non-diseased and Diseased Thyrocytes; Expression of Receptors at Low and
High Densities.
Thyrocyte type

Low TSHr density

High TSHr density

Total

Ml (%)n

M2 (%)n

(%)

Non-diseased cells

55 7-5

45 7_3

100

Diseased cells

28 7_4

72 7-4

100

n = 6. The number of times the experiment was repeated. Student's Y test determined
that TSHr density was significantly different between non-diseased and diseased thyrocytes
(p< 0.001).
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D. PHASE 4: Gap Junctional Communication in Fisher Rat Thyroid Cells;
The Absence of Connexin 43 and The Role of Connexin 32 in
follicle formation.
Fisher Rat Thyroid Line-5 (FRTL-5) are clonal cells that have been extensively
utilized in thyroid research to mimic primary thyrocytes. The literature reports
FRTL-5 cells retain differentiated characteristics and properties of thyrocytes despite
the culture selection process necessary to develop clonal cells. However, differences in
thyroid function are observed when FRTL-5 cells are compared to primary rat thyroid
cultures (155).
It has been determined that gap junctional communication is a ubiquitous
process critical in the control of growth, development and coordination of cellular
functions (25-27). We have established gap junctional communication is an important
factor necessary for normal thyroid function with reduced communication contributing
to the abnormal thyroid function (e.g. reduced release of T4) observed in autoimmune
disease. Therefore, to determine if FRTL-5 cells retain certain physiologic thyroid
properties that make them reliable corollaries to normal thyroid cells, we assessed their
communication status as an index of their normalcy.

1.

Comparative Assessment of Thyroglobulin Concentrations in Supernatants
Obtained from Cultured FRTL-5 Cells.
Preceding the assessment of Tg production in FRTL-5 cells, we confirmed that

these cells produce Tg which is characteristic of thyroid cells. The FRTL-5 cells were
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fixed, immunolabeled for Tg expression and determined to stain heavily in the
cytoplasm for Tg in contrast to the negative control, fetal rat lung cells (data not
shown).
The supernatants were obtained from equivalent 7-9 day cultures. Three
separate cultures with six replicate samples/sample were used to obtain these results.
We used the solid phase ELISA we developed to quantitate the amount of Tg in these
supernatants. The positive and negative controls were bovine Tg and supernatant from
normal primary thyrocyte cultures. Thyroglobulin concentrations were significantly
higher (63%) in the supernatants of FRTL-5 cells when compared to the supernatants of
primary thyrocytes (362 7_ 3.5 versus 170.5 7_ 4.5 (p< 0.001 in 6 replicates) as seen
in Figure 24.

2. Immunocytochemical Localization of Gap Junctional Proteins Connexins 43,
32 and 26 in FRTL-5 Cultures organized as Monolayers.
Connexin protein expression and distribution were assessed in cultured, fixed
FRTL-5 monolayers. Figure 25 depicts immunolabeling for Connexin 43 (panel a),
Connexin 32 (panel b) and Connexin 26 (panel c). Thyroid cells were negative for
Connexin-protein 43 and positive for Connexin-proteins 32 and 26. Primary anti-sera
binding is visualized as punctate fluorescence, corresponding to aggregates of connexin
channels in the form of gap junctional plaques. The discrete punctate fluorescence
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Figure 24. Comparative Assessment of Thyroglobulin Concentrations in obtained
from FRTL-5 Cultures. A solid phase ELISA utilizing a rabbit anti-thyroglobulin
antibody, bovine Tg, peroxidase-tagged goat anti-rat IgG antibody and TMB substrate
detected thyroglobulin concentrations. Tg concentration in FRTL-5 cells was 63% higher
than the negative control FRL cells (362 7_ 3.5 versus 170.5 +/_ 4.5 (p< 0.001) for
replicates of six in three separate experiments. The positive control was bovine Tg.
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Figure 25. Immunocytochemical Localization of Gap Junctional Proteins Connexins 43, 32 and 26 in FRTL-5 Cultures
organized as Monolayers. Cells were fixed and immunolabeled with rabbit polyclonal anti-sera specific for; Connexin43
(panel a), Connexin 32 (panel b) and Connexin 26 (panel c). Aggregates of connexin protein assembled into gap junctional
plaques in contacting membranes are detected as discrete punctate immunofluorescence. Connexin 43 (panel c) was noticeably
absent with heavy labeling for Connexin 26 (panel c) and less moderate labeling for Connexin 32 (panel b) at contacting
intercellular membranes. Non-immune rabbit sera and fluorescent secondary antibody controls were used for negative controls
(not shown). Magnification 630X.
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corresponding to aggregates of connexins 32 and 26 were located in the plasma
membranes of the FRTL-5 cells (panels b and c). The absence of Connexin 43
fluorescence indicates a lack of Connexin 43 protein. Monolayers were modulated with
Forskolin for 3, 6 and 12 hours to activate protein kinase A in an effort to upregulate
Connexin 43-mediated communication. However, despite our efforts to upregulate
Connexin 43, it was not expressed (data not shown).

3. Immunocytochemical Detection of Connexins 43, 32 and 26 in Cut Sections of
FRTL-5 Cultured Follicles.
FRTL-5 cells initially form monolayers but predominantly grow and persist as
follicles. To determine if the absence of Connexin 43 was a consequence of the
monolayer conformation, connexin labeling was repeated in fixed fresh samples of
cultured follicles cryosectioned to expose the internal follicular structure.
Figure 26 depicts immunolabeling for Connexin 43 (panel a), Connexin 32
(panel b) and Connexin 26 (panel c). The cryosections of the follicle were again
negative for Connexin-protein 43 and positive for Connexin-proteins 32 and 26.
Connexin 43 fluorescence was absent in follicles (panel a) indicating a lack of
Connexin 43 gap junctions as was observed in monolayers. Discrete punctate
fluorescence corresponding to aggregates of connexins immunolabeled positive for
Connexins 32 and 26.

to

Figure 26. Immunocytochemical Detection of Connexins 43, 32 and 26 in Cut Sections of FRTL-5 Cultured Follicles.
Follicles were cultured, cryosectioned, fixed and immunolabeled for Connexin 43 (panel a), Connexin 32 (panel b) and
Connexin 26 (panel c). Follicles depict the three dimensional in vivo thyroid follicular structure. Connexin 43 was absent with
moderate labeling for Connexin 32 (panel b), and high levels of Connexin 26 (panel c) at contacting intercellular membranes.
Magnification 630X.
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To determine if the lack of Connexin 43 was evident at the message level
(mRNA) we performed northern blot analysis.

4. Northern blot analysis of Connexins 43, 32 and 26 in FRTL-5 cells
Total RNA was extracted and hybridized with connexin-specific cDNAs to
determine if the absence of Connexin 43 in the cultures was coincident with a reduced
connexin transcript. The amount of total RNA loaded in each lane was
densitometrically equivalent. The results shown in Figure 27 revealed that the
hybridization signal for Connexin 43 was absent. Inspite of efforts to upregulate the
message, with Forskolin Connexin 43 mRNA transcript remained undetectable. In
contrast, Connexin 32 mRNA was detected FRTL-5 cells (lanes 3,4 and 5).
Densitometric analysis revealed no change in Connexin 32 with Forskolin modulations
(lanes 4 and 5). The levels of Connexin 26 in FRTL-5 cells were too low to be
detected (lanes 3, 4 and 5) inspite of the significant levels of Connexin 26 protein
expressed. The results from three separate experiments varied by approximately
+1- 5% of the values depicted in Figure 27.

5. Intercellular Communication in Monolayers and Follicles of Cultured FRTL-5
Cells.
The absence of Connexin 43 protein and mRNA transcripts in FRTL-5 cells
suggests a possible loss of function. To determine if this absence of Connexin 43 was
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Figure 27. Northern Blot Analysis of Connexins 43, 32 and 26 in FRTL-5 Cells.
Shown are the results of hybridization of northern blots containing total RNA with
connexin-specific cDNAs. Ribosomal bands are marked with arrows. The lanes are;
Fetal rat lung (FRL in lane 1), rat liver (lane 2), FRTL-5 untreated (lane 3), FRTL-5
with a 3hr Forskolin treatment (lane 4), FRTL-5 with a 6hr Forskolin treatment (lane
5), rat thyroid (lane 6) and rat myometrium (lane 7). Connexin 43 is absent in FRTL-5
cells (lane 3). Treatment with Forskolin did not reveal Connexin 43 mRNA transcripts
(lanes 4 and 5). Connexin 32 is evident in FRTL-5 cells (lane 3) with no changes on
incubation with Forskolin (lanes 4 and 5). Connexin 26 was to low to detect in FRTL5 cells (lanes 3, 4 and 5).
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associated with reduced cell-cell communication, microinjections were conducted on
both monolayers and follicles of FRTL-5 cells. Monolayers (Figure 28, panels a
and b) did not transfer dye from the injected cell to adjacent cells (n=50). In contrast.
follicular cultures (Figure 28, panels c and d) transferred dye to third and fourth order
contacting cells in the majority of trials. Primary and secondary transfer occurred in
all the trials (n=50). See Table 7 for compiled results.

Table 7.

Comparative Assessment of Dye Transfer in Monolayers and Follicles of
FRTL-5 Cells.

Degree of dye transfer®

Monolayerb(%)

Follicleb (%)

Primary

0

100

Secondary, Tertiary &

0

90

Quartenary

a) Primary = dye transfer from the injected cell to cells in direct contact. Secondary
tertiary and quartenary = dye transfer from the injected cell to peripheral cells not
in direct contact, but separated by one, two or three intervening cells, respectively.
b) Percentage based on 50 injections from 3 different cultures tested between days 7-10.
*) Dye transfer images were captured at one and two minutes after injection, percentage
calculations were made from the extent of dye transfer at two minutes.
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Figure 28. Intercellular Conununication in Monolayers and Follicles of Cultured
FRTL-5 Cells. The composite is arranged with the phase images (panels a and c) next
to their corresponding fluorescent images (panels b and d). The phase images indicate
the extent of membrane contacts not evident from the fluorescent images alone. Panels
(panel a and b) are monolayers and panels (panels c and d) are follicles. An arrow
indicates the cell that was microinjected. The monolayer did not transfer dye to
adjacent cells (panel b). In contrast, the cells in follicles transferred dye to primary,
secondary and tertiary to contacting cells (panel d). Microinjection experiments were
performed on monolayers and follicles n=50. Magnification 400X.
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6. Evaluation of The Karyotype of FRTL-5 Cells.
The chromosome constitution of cells in vitro is one of the most useful criteria
for monitoring “normalcy” in cell populations (123). To determine if chromosomal
abnormalities were responsible for the lack of Connexin 43 in FRTL-5 cells
karyotyping was conducted. The cells were cultured and allowed to grow into
follicular structures before being harvested. Chromosomal mapping identified 22 pairs
of chromosomes with no missing chromosomes. The chromosomes were all paired
with no visible structural abnormalities, translocations or truncations. Banding patterns
appeared to match normal rat cell banding patterns (124). Southern blot analysis of the
gene and in situ hybridization is currently in progress to determine if the gene is
missing or is inactive, thus the data is not shown. However, a combined analysis will
soon be published in a manuscript currently in progress.

CHAPTER FOUR
DISCUSSION

A. PHASE 1: Characterization of Disease and Reduced Cell-Cell
Communication in Experimentally Induced Autoimmune Thyroiditis.
Autoimmune diseases are initiated by autoreactive lymphocytes and their
products (20). Current models of autoimmune thyroiditis suggest that the destruction of
thyrocytes (thyroid epithelial cells) by infiltrating lymphocytes and their products cause the
loss of target tissue function (i.e. hypothyroidism) (156). Our original premise was that
inflammation-induced tissue disruption would decrease gap junctional mediated cell-cell
communication in induced experimental autoimmune thyroiditis.
Lewis rats were selected for this study since they have provided a model for
adjuvant induced arthritis (157,158) and adoptive transfer of experimental autoimmune
encephalitis (135,159). This strain is not commonly used for the induction of autoimmune
thyroid disease. However, older studies report that Lewis rats develop lymphocytic
infiltration of the thyroid gland and anti-Tg antibodies following injections of altered or
heterologous Tg (135). In our studies, heterologous Tg and thyroid extracts were used to
induce thyroiditis. The plasma membranes were removed from the extracts prior to
administration to prevent the development of TSHr -autoantibodies which can stimulate
the TSHr and produce a syndrome similar to Grave's disease (160). The sera from
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diseased rats did not appear to contain either TSHr stimulating or inhibiting antibodies, as
they did not interfere with TSH added to the cultures (data not shown).
Four aspects of the thyroid disease which we induced in these rats are virtually
identical to spontaneous human autoimmune thyroiditis (Hashimoto's thyroiditis) (19) and
to a spontaneous murine model of autoimmune thyroiditis which we have recently
described in MRL-lpr/lpr mice (21,180). 1) The thyroids from the treated rats were
infiltrated with lymphocytes and contained lymphoid follicles. 2) The treated rats
developed hypothyroidism with decreased T4 and elevated TSH (125). Free T4
measurements better reflect thyroid function than either total- T4 or bound T4- serum
levels because free T4 levels are not subject to fluctuations in thyroid hormone binding
protein levels (161,162). Additional signs of hypothyroidism were also observed in the
diseased rats which included a loss of fur, predominantly around the head area, and a
general lethargy that was not evident in the non-diseased rats. 3) High titers of IgG
autoantibodies against Tg and TPO were present in serum. Our results document that the
anti-TPO antibodies measured did not cross-react with epitope(s) on Tg (136). These
anti-TPO antibodies are important since their titer in spontaneous human thyroiditis
correlates better with the degree of inflammation than titers of anti-Tg antibodies (163).
This relationship was also true in the Lewis rat induced model where there was a direct
correlation of circulating anti-TPO antibodies with lymphocytic infiltration. 4) The
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diseased thyroid tissue expressed increased levels of MHC class II antigens. This
abnormality is not seen in other induced models for autoimmune thyroiditis (20), and
suggests that the Lewis rat may be a better model for human thyroid disease than other
induced animal models.
Since the serology and histology were similar to the spontaneous model, we used
thyroid tissue from this induced model to examine connexin expression and gap junction
abnormalities. All three connexin proteins were reduced in thyroid tissue from
experimental rats. More importantly the connexins were located in the cytoplasm and
were not assembled into gap junctions in plasma membranes as they were in control rat
thyroid tissues. These connexin and gap junction abnormalities are similar to those
present in MRL-lpr'/lpr mice (164). The difference between these animal models, in terms
of connexin expression, was that Connexin 32 protein concentration was not reduced in
the diseased mouse thyroid.
Decreased connexin protein was associated with reduced connexin transcripts.
The presence of infiltrating lymphocytes in the preparations from diseased thyroids could
contribute to the total RNA loaded onto the gels. This could lead to under-representation
of RNA from the diseased thyroid cells. Based on the histologic studies and the extraction
procedure it is unlikely that lymphocyte RNA was greater than 10% of the total RNA.
Although a truly quantitative comparison cannot be made it still appears that there is a
decrease in all three connexin mRNAs in the diseased gland.
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The significance of reduced connexin mRNA is uncertain. The minimum level of
connexin transcript needed to produce sufficient connexin protein has not been
determined. For example, there are cells that lack gap junctions and do not communicate
that nevertheless express high levels of connexin mRNA (37). This suggests that the
quantity of transcript may be less important than other factors such as post-translation
processing, translocation and insertion of connexin protein into the plasma membrane or
assembly and aggregation of connexins into gap junctions. The current study does not
distinguish between these possibilities.
Inflammatory cells may alter thyroid gap junctional communication by the release
of factors which could modulate connexin production, insertion and assembly, or by
physical disruption of cell contacts. The regulation of connexin expression and subsequent
regulation of gap junctional assembly and function have not been fully elucidated.
Connexin 43 and Connexin 32 are phosphoproteins whose processing, assembly and
function appear to be regulated by protein kinases (37,80). Biologically active cytokines
such as interferon- (IFN-y), interleukin-1 (IL-1) and tumor necrosis factor-a (TNF-a) may
be elaborated by infiltrating lymphocytes present at sites of inflammation and subsequently
mediate the activation or inactivation of protein kinases (18,164) and thus potentially
regulate connexin production or function in vivo.
An alternative mechanism by which inflammation may alter intercellular
communication is physical disruption of the environment. In our studies the intact thyroid
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tissue infiltrated by lymphocytes may have reduced cell contacts. In order to limit physical
barriers and to remove biologically active factors released by those lymphocytes we
established primary cultures of thyrocytes isolated from normal and diseased rats. We
then determined whether thyrocytes isolated from the diseased thyroids would reestablish
connexin production and cell-cell communication. The viability and extent of contact
between cells from the normal and diseased rats did not differ.
Several technical factors are important to consider in order to interpret these dye
transfer studies. 1) A number of different matrix preparations were compared in the initial
experiments to establish the thyroid cells in culture. The components tested included
vitronectin, enactin, laminin, fibronectin, collagen and various combinations of these matrix
factors. There was virtually no difference in the plating efficiency, growth, viability, state of
differentiation, or cell-cell communication with the use of any of these mixtures (data not
shown). Therefore type I collagen from rat tail was used for all cultures. 2) Theoretically, the
cell populations isolated from the normal and diseased thyroids could be different due to the
presence of lymphocytes and other inflammatory cells in the diseased thyroids. Virtually all
cells (> 98%) labeled with antibody to Tg demonstrating that there was minimal contamination
by inflammatory cells and excludes overgrowth by fibroblasts. Furthermore, it demonstrates
that the cultured cells maintained a normal thyrocyte phenotype. 3) Although the diseased
cells contain Tg they did not form follicles to the same degree as cells isolated from normal
animals. To maintain uniformity in the experimental and control cultures we used conditions
that supported monolayers but did not promote follicle formation in the normal cells unless
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needed. 4) As with many differentiated epithelial cells the thyrocytes from both normal and
diseased animals "age" in primary culture. With long term cultures the cells retract from each
other and ultimately become communication deficient (96). All connexin and communication
studies were done on culture days 6-7, a time point prior to this "aging" process.
The cultured cells from normal thyroids rapidly establish gap junctions.
Furthermore the cultured normal cells transferred LY dye. Despite reestablishing physical
proximity and removing the inflammatory products of reactive lymphocytes the diseased
thyroid cells continued to have reduced connexin proteins, abnormal localization of
connexin to the cytoplasm, and did not transfer dye. This strongly suggests that decreased
dye transfer was due to a decreased connexin production and impaired assembly of connexins
into functional connexon channels. Thus physical disruption is not the cause of reduced gap
junction-mediated cell-cell communication. If factors released by the inflammatory cells
are responsible for the observed abnormalities, these cytokines would have to persist in
culture for > 6 days to exert the effects on connexin production and formation of
functional gap junctions that we have measured. Initial tests of our primary culture
supernatants indicate that TNF, IL-1 or IL-6 are not present (data not shown, sensitivity
of the assays ranged from 10-200 pg/mt). We have not yet established whether there are
differences in thyroid hormone synthesis in these cultures.
Like other endocrine tissues (167) the thyroid may have a non-homogeneous
distribution of TSH receptors. Thus when TSH binds to TSH-receptor bearing cells the signal
would normally be sent through connexin channels to contacting and even to distant follicular
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cells which lack TSH receptors. This would result in a coordinated response to TSH and
increase the production and release of thyroid hormones. As we have seen, the diseased rats
are relatively hypothyroid. The physical infiltration of inflammatory cells in this autoimmune
thyroid disease may lead to separation and disruption of follicular epithelial cells. However,
our results demonstrate that the thyroid tissue and cells isolated from these thyroids have
reduced connexin and aberrantly located connexin aggregates and that the cultured cells
exhibited less cell-cell communication. This may provide an additional mechanism for deficient ’
thyroid hormone secretion even when the physical disruption in vivo is limited.
The thyroid cells isolated from diseased rats formed fewer and smaller follicles in
culture than cells isolated from the control rats. A recent study with cultured normal
porcine thyroid epithelial cells showed that Connexin 32 and Connexin 43 were
differentially expressed as a function of morphologic changes and follicle formation (168).
In that study Connexin 32 protein was undetectable 24 hours after plating but reappeared
when the cells were induced to form follicles either by increased plating density or by the
addition of TSH. In contrast, Connexin 43 protein increased steadily with time in culture
irrespective of follicle formation (168). In our studies the cultured normal rat thyrocytes
in monolayers contained predominantly Connexin 43. Whereas, Connexin 32 was the
major connexin protein in the tissue sections where thyroid cells are present in follicles.
Furthermore, in the normal rat thyroid we observed a discrete localization of connexins
with Connexin 32 junctions between cells within a follicle, Connexin 43 at the basal
surface of cells with contacts between cells in different follicles, and Connexin 26 at the
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lumenal surface of the cells in follicles. This distribution suggests that each connexin could
have a specific or unique role in signaling, in Tg or thyroid hormone transport, or in tissue
organization. The same specific pattern of connexin localization is seen in normal mouse
thyroid (21) demonstrating the pattern is not unique to or species specific.
The principal manifestation of autoimmune thyroid disease is hypothyroidism.
Current models of autoimmune thyroiditis postulate that the reduction in thyroid hormone
release is occurring through immune mediated destruction of the thyroid cells (20).
Destruction of thyroid cells associated with extensive fibrosis and replacement of thyroid
epithelium, as well as other destructive processes, occurs late in the disease and clearly
contributes to diminished thyroid function. However, these events do not explain the
hypothyroidism that occurs earlier in the disease process. The findings presented here
established that heterologous Tg-thyroid extracts induced an autoimmune thyroid disease
in Lewis rats similar to spontaneous autoimmune thyroid disease in humans and a
spontaneous murine model. Thus these abnormalities are not limited to either the mouse or
to the induced autoimmune thyroid disease in Lewis rats. The rat model demonstrates a
clinically relevant abnormality of reduced thyroid hormone secretion which occurs prior to
extensive destruction of the thyroid gland in vivo. The disorder is further characterized by
reduced quantities of multiple connexin proteins, mRNA and lack of assembly of those
connexin proteins into functional gap junctions. These abnormalities persist even in the
absence of the physical disruption and biologically active products of the inflammatory
cells. These findings are consistent with the possibility that connexins/gap junctions may
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be critical to normal thyroid follicle formation and subsequently to thyroid hormone
synthesis, storage and release. Lastly the discrete localization of specific connexin gap
junctions suggests that each connexin type may have a unique role in thyroid function and
cellular organization.

B. PHASE 2: Elevated levels of Protein Kinase C Isozymes in Experimental
Autoimmune Thyroiditis Prevent the Assembly of Connexin 43 Gap Junctions
and Reduce Intercellular Communication.

Our initial characterizations of rat (experimental) and mouse (spontaneous) models
of autoimmune thyroiditis (21,35) describe a disease process with striking similarities to
human autoimmune thyroid disease. Current models of autoimmune disease suggest that
the immune response causes target tissue destruction. However, temporal analysis of
changes in thyroid tissue during disease progression revealed that hypothyroidism occurs in
the absence of cytotoxic destruction and is associated with alterations in structural (connexin
assembly into gap junctions) and functional (dye transfer) measures of intercellular
communication. The current study further explores the role of pKC as a potential regulator
of Connexin 43-mediated intercellular communication. Recent evidence suggests that the
induced production of

interferon (169) and tumor necrosis factor-alpha (TNF-a)

(170) by autoreactive lymphocytes also occurs by a pKC-mediated pathway (171). [These
cytokines synergistically induce the expression of MHC-class II antigens and ICAM-1 on
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thyroid cells whose function is most likely the attraction and retention of lymphocytes in the
target tissue (20).]
The initial observation that monolayer thyrocytes predominantly produce
Connexin 43 (21,35) [which is regulated by phosphorylation {Reviewed in: 80)] led us to
question whether an elevation in basal protein kinase levels could be responsible for the
reduction in Connexin 43 gap junctions and subsequent loss of intercellular communication
in autoimmune diseased thyrocytes. The level of total cAMP dissociable pKA activity was
determined not be significantly different in cell lysates from digested thyrocytes from EAT
and control animals. However, pKC activity was 78% higher in thyrocytes from EAT rats
compared to thyrocytes from control rats. We qualitatively compared the relative levels of
four pKC isozymes; alpha, beta, delta and epsilon in thyroid tissue from EAT and control
rats using immunocytochemistry. Apparent differences between these four pKC isozymes
were followed up quantitatively by Western blot analyses of eight pKC isozymes in freshly
isolated thyrocytes from EAT and control rats. Elevation in pKC alpha, beta, delta, and
epsilon can account for approximately 30% of the increased pKC activity in thyrocytes of
EAT rats. The remaining 50% increase may be attributed to induction of pKC gamma and
lambda in diseased thyrocytes, but were not expressed at detectable levels in control rat
thyrocytes. These findings strongly suggest that these six pKC isozymes of pKC may play
a special role in mediating target tissue changes leading to loss of function in autoimmune
thyroid disease.
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To determine whether a causal relationship exists between changes in pKC activity
and the Connexin 43 gap junction deficits and functional loss of intercellular communication
associated with EAT, we modulated pKC activity and assessed the effects on intercellular
dye transfer between thyrocytes and localization of immunoreactive Connexin 43 within
monolayer thyrocyte cultures. Cell monolayers cultured from thyrocytes of normal
(control) rats lost intercellular communication and Connexin 43 gap junctions when
incubated with OAG, an analog of diacyl glycerol which increases pKC activity. The loss
of intercellular dye transfer was indistinguishable from that observed in untreated thyrocyte
monolayers from EAT rats (p > 0.05, Chi-square analysis). OAG has been reported to
preferentially activate the calcium dependent forms of pKC (isozymes alpha, beta, and
gamma) (60). These are three of the six pKC isozymes we have shown to be up-regulated
in thyrocytes from EAT rats. In previous experiments, a two-fold increase in these
calcium-dependent pKC isozymes decreased Connexin 43 gap junction assembly and
functional intercellular communication (dye transfer) in ovarian granulosa cells (102) and a
fetal rat lung cell line (unpublished observations). Calphostin C at 100 nM is specific in its
down-regulation of pKC, but does not distinguish between the pKC isozymes (70). Down
regulation of pKC in thyrocytes from EAT rats restored intercellular communication to a
normal level [i.e. no significant difference (p > 0.05) from dye transfer in untreated
thyrocyte monolayers cultured from normal (control) rats by Chi-square analysis].
Experiments are now underway to determine the effects of stimulation and inhibition of
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individual pKC isozyme expression in thyrocytes on thyroid function using molecular
biology approaches (sense and antisense strategies).
As yet, our studies have not addressed the mechanism responsible for the sustained
elevation of pKC activity in autoimmune diseased thyroid tissue. Our thyroid cultures from
diseased thyroid tissue are free of contaminating lymphocytes. Thus, lymphocyte-derived
cytokines are not responsible for the sustained elevation in pKC levels which we detect.
Thyroid cells undergoing various disease processes and experimental conditions have been
reported to themselves produce cytokines (172). Several studies using reverse transcriptase
polymerase chain reaction (RT-PCR) and Northern blot analysis report that thyroid cells
contain mRNA corresponding to interleukin (IL)-1, IL-6, IL-12, gamma-'mtzxfzvon, and
TNF-a (172,181,182). On a protein level, IL-1 and IL-6 are the most frequently reported
cytokine products of thyroid cells (173). There are conflicting reports as to the thyrocyte
protein production of TNF-a and interferon-gam^ (174,175). Conditioned media from
our thyroid cultures do not contain detectable levels of TNF-a. We have also not detected
interleukin-1 or interleukin-6 under the conditions we employ for culturing primary rat and
mouse thyroid epithelial cells (unpublished results). We have not tested for the presence of
gamma-interferon in our thyroid cultures. An exact consensus as to which cytokines are
produced by the thyroid awaits further investigation; however, cytokine production may be
dependent on the age of the cells, and/or the stage of the disease process as previously
suggested (173). Therefore, at this time we cannot rule out an autocrine mechanism in
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which a thyrocyte-derived cytokine maintains the up-regulation of pKC in the autoimmune
diseased thyroid cells.

C. PHASE 3: Enhanced TSH Receptor Expression and Increased Metabolic
Activity in Experimentally Induced Autoimmune Thyroid Disease.
Phase three of our project was designed to help us understand the contributions of
the TSHr to the disease process in EAT.
To understand the differences observed in the cultures and supernatants of
diseased thyrocytes compared to non-diseased cultures, we examined the cellular
expression of Tg and measured Tg concentrations in their supernatants. We found
diseased thyrocytes expressed more Tg (36%) than non-diseased thyrocytes, this
suggested that the diseased cells were metabolically accelerated.
To test this we determined the mitochondrial activity of thyrocytes. We found the
metabolic activity was 33% higher in diseased thyrocytes which demonstrated that these
cells were metabolically accelerated compared to non-diseased thyrocytes. This may
explain why diseased thyrocyte cultures have a more rapid establishment, growth and
senescence. It is possible the conditioned media contains factors in addition to Tg
(Figure 18), for example thyroid-derived cytokines, which may be responsible for the
target tissue-mediated disease process.
Though pKA activity was normal in diseased thyrocytes, we wanted to confirm
that the pKA pathway was functioning normally. Basal cAMP levels were not
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significantly different in diseased thyrocytes. Preliminary modulation studies of the pKA
pathway did not appear abnormal. These results demonstrate that 1) the pKA pathway
functions normally in diseased thyrocytes, 2) the TSHr is linked to the cAMP-dependent
pKA pathway and tranduces signals normally and 3) the elevated pKC activity is not
directly associated with TSHr abnormalities in the diseased thyrocytes.
To further investigate the TSHr and potential differences in diseased and nondiseased thyrocytes we measured TSHr surface density. We found a 27% increase in TSH
receptors expressed on diseased thyrocytes which does not appear to be linked to the
elevated pKC activity. A recent report in FRTL-5 cells confirms that when the TSHr
engages the inositol phosphate pathway it does so through an additional cofactor. Thus,
the TSHr is not directly linked to pKC confirming our observations (177).
Further analysis of TSHr distribution demonstrated a heterogeneous expression of
TSH receptors in both non-diseased and diseased thyrocytes (Table 6). This may explain
the coordination provided by gap junctions to heterologous responses of endocrine cells
that result in an enhanced or more efficient release of hormones (47,166).
The expression of pKC isozymes; alpha, beta, delta, and epsilon was elevated by
30%. It appears that Tg production, mitochondrial activity and pKC isozyme expression
may be regulated by the same mechanism as they all demonstrate an approximate 30%
increase in diseased thyrocytes.
We have shown that target tissue maintain their disease phenotype despite the
removal of cytokines and lymphocytes that suggests this undefined mechanism is target
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tissue-derived. Current studies have demonstrated that immune-derived cytokines cause
inflammation by pKC-mediated processes which include the release of cytokines and their
subsequent pathogenic effects (178). Thyrocytes have been shown to release cytokines in
culture. These findings suggest that thyroid target tissue may cause inflammation by pKC
mediated processes. Our finding of an elevated pKC activity in diseased thyrocytes
supports this premise. Therefore, an autocrine mechanism may be responsible for the
sustained contribution of the target tissue to EAT, wherein the diseased thyrocytes release ’
cytokines by pKC-mediated processes that then contribute to pKC-mediated events.
Therefore, the identification of disease-mediating factors released by diseased
thyrocytes has great potential. It will enable us to understand how target tissue
contributes to the disease process in EAT, and further, why the disease is sustained after
removal of inflammatory mediators. Preliminary studies in our laboratories have
demonstrated that factor/s secreted by diseased thyrocytes can cause gap junctional
abnormalities in normal thyrocytes. However, this needs to be further explored.
In defining a therapeutic model, our study of pKC involvement in the loss of target
tissue function could have important implications for the development of future therapeutic
approaches to reduce and, potentially, reverse the adverse effects of chronic tissue
inflammation. Much of the morbidity resulting from autoimmune disorders is proportional
to the extent of the inflammation and its chronicity. Current treatment is largely
immunosuppressive in an attempt to control the amplification of reactive T-cells and depress
autoantibody production. However, this strategy seems only to reduce the symptoms and
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has numerous deleterious side effects, e.g. compromising the immune system. Continued
loss of target function in spite of immune suppression is consistent with our observation that
pKC-mediated changes in intercellular communication persist in EAT thyrocytes in vitro in
the absence of lymphocytes or their cytokine products. Bisindolylmaleimides, potent and
specific inhibitors of protein kinase C, are an alternative approach currently being evaluated
for their potential use as topical anti-inflammatory agents (179). Although these compounds
were originally chosen for their inhibition of pKC-mediated cytokine release by autoreactive
lymphocytes, our findings strongly suggest that the efficacy of these agents will also be due
to their ability to reverse the elevation of pKC activity in target tissue. Thus, pKC
inhibitors could play an important role in retaining, and potentially restoring, target tissue
function. New therapeutic approaches targeting the mechanism(s) of target tissue
dysfunction could reduce suffering and may relegate immunosuppressive chemotherapy to
initial and acute flares of autoimmune disease.

D. PHASE 4: Gap Junctional Communication in Fisher Rat Thyroid Cells;
The Absence of Connexin 43 and The Role of Connexin 32 in Follicle
Formation.
FRTL-5 cells were evaluated to determine the validity of using them as an
additional control for primary thyrocytes. FRTL-5 cells have been extensively used to
research thyroid function because they continue to divide in culture and retain many
thyroid properties. However, FRTL-5 cells have aberrant responses to epidermal growth
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factor and display other contradicting differences in thyroid hormone synthesis (23) which
suggest they have inherent abnormalities and do not mimic primary thyrocytes as reliably
as previously thought.
Here, we examined contact-dependent cell to cell communication in FRTL-5 cells.
Because intercellular communication is ubiquitous and is implicated in the control of
growth, differentiation and metabolic processes we wanted to determine if FRTL-5 cells
displayed normal intercellular communication. This study of gap junction-mediated
intercellular communication paralleled some aspects of our work described for
experimental autoimmune thyroiditis in Lewis rats (Phase 1). Thyroid function depends
on the three dimensional follicular organization (163) therefore, we examined FRTL-5
cells as monolayers and follicular structures. We found that FRTL-5 cells produced
thyroglobulin and therefore retained a function of differentiated thyroid status.
We have shown primary thyrocytes express three connexins, Connexin 43,
Connexin 32 and Connexin 26 which have a tendency to localize to different interfaces of
the thyroid follicular structure (21,35). Connexin 43 was predominantly basal.
Connexin 32 lateral and Connexin 26 apical (Phase 1). Connexin 43 is the predominant
connexin in primary thyrocytes organized as monolayers (21,35). Surprisingly Connexin
43 was not expressed in monolayers of FRTL-5 cells.
Connexin 32 appeared as the FRTL-5 cells started to form aggregates. In porcine
primary thyrocytes, Connexin 32 and Connexin 43 are differentially expressed during
follicle morphogenesis. Connexin 32 mRNA is expressed just before the formation of
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follicles in response to TSH or increased density. The elevation in Connexin 32 is
sustained and continues to increase with follicular formation (168). In contrast,
Connexin 43 mRNA consistently increases in cultures not related to follicular structure.
Connexin 26 was heavily expressed in the FRTL-5 cells organized as monolayers
but did not contribute to dye transfer. Connexin 26 fluctuates with cell cycle changes and
is expressed in many endocrine and exocrine glands at variable levels (15). However,
Connexin 26 is not expressed in dog and porcine thyrocytes nor does it appear to be a
communicating connexin in FRTL-5 monolayers. The function of Connexin 26 in the
thyroid is not well understood and needs to be further investigated before any conclusions
can be made about its contribution to thyroid function.
In FRTL-5 follicles, cut sections revealed Connexin 43 was not expressed.
Connexin 32 was heavy and predominantly lateral, whereas Connexin 26 was found mainly
on the apical interface. The differential localization of Connexin 32 and Connexin 26 in
cultured FRTL-5 follicles was similar to that seen in rat thyroid sections and in cultured
follicles ((Phase 1,21,35).
To document levels of message for Connexin 43, Connexin 32 and Connexin 26
we did northern analysis. Connexin 43 mRNA was absent despite our attempts to
upregulate it through the cAMP-dependent pKA pathway. Connexin 32 and Connexin 26
are relatively uninducible by protein kinases at a message level. We also saw no change in
the mRNAs of these connexins.
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To determine whether the expressed gap junctions were correctly assembled we
tested their functional capacity. Dye transfer between a cell microinjected with fluorescent
dye and contacting neighboring cells is a functional measure of intercellular communication
and is dependent on correctly assembled gap junctions in contacting plasma membranes.
Untreated normal thyrocyte monolayers transfer dye to primary, secondary and tertiary
contacting cells in 98%, 80% and 70% of trials (Figures 11, panel b, and 14 panel b,
Tables 2 and 4). FRTL-5 cells organized as monolayers failed to transfer dye to any
contacting cells. This is not surprising because of their lack of the predominantly
monolayer connexin, which is Connexin 43-type gap junction.
Within the follicles, tertiary and quartenary dye transfer occurs in 90% of the
injections demonstrating that Connexin 32 has to be responsible since it is the only
functional gap junction expressed by these cells. Current models suggest connexins have
specific functions for which they are differentially located. The possible mediation of
communication by Connexin 32 in follicles, and its specific localization led us to examine
the contributions of Connexin 32 to thyroid physiology. The organization of thyrocytes
into follicles is necessary for synthesis and secretion of thyroid hormones (163,168).
Follicles form intimate associations with matrices, adhesion molecules and C cells to form
the thyroid gland and coordinate thyroid function (163,168,176). Follicle morphogenesis
involves aggregation, polarization and lumen organization (59). Connexin 32 assembly
into gap junctions and E-cadherin expression are increased during follicle morphogenesis
and are preceded by an increase in their respective mRNA levels suggesting that
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Connexin 32 and E-cadherin may contribute to follicle formation (59,168). E-cadherin is a
cell-cell adhesion molecule found on nearly all polarized epithelial cells (59). In thyroid
cells it is initially found subapically, but accumulates at the lateral interface in mature
follicles suggesting it contributes to cell polarization and correct expression of the apical
membrane (59). In hepatocyte cultures, components of extracellular matrix specifically
proteoglycans and glycosaminoglycans enhance the function of Connexin 32 wherein the
magnitude and duration of coupling was increased (16). We believe E-cadherin, and
extracellular matrices participate in the formation of gap junctions and assembly of follicles
by inducing aggregation of cells (56,58,176). We found reduced Connexin 32 (Phase 1)
and abnormal E-cadherin in rat tissue sections and cultured cells with induced autoimmune
thyroiditis (manuscript in progress). This may explain the failure of diseased thyrocytes to
assemble equivalent follicles in vitro.
Our studies have not yet completely addressed the contributions of Connexin 43 and
the implications of the loss of this connexin to thyroid function in FRTL-5 cells. Rat
thyroid tissue sections were compared to in vitro cultures wherein the basal localization of
Connexin 43 suggests it coordinates function with bordering cells including thyrocytes of
other follicles, matrices or interfollicular C cells. Previous studies report the expression of
Connexin 43 in C cells (163) and the regulation of Connexin 43-mediated communication
by E-cadherin (56,57). These findings may explain the failure of cultured thyrocytes to
assemble into multifollicular structures in vitro.
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A consistent pattern of differential expression of Connexins 43 and 32 has been
reported in a number of cell types, wherein Connexin 43 was expressed in endocrine cells
and Connexin 32 found only in exocrine cells (15). From this, it has been posed that
during embryonic development connexins may designate endocrine or exocrine
lineages (15).
Connexin 43 is found in most cell lines and nearly all primary epithelial cells (37).
It was therefore surprising that Connexin 43 was absent from the FRTL-5 cells. To
examine this at the chromosomal level, we performed a karyotype on the cells to look for
chromosomal abnormalities. The karyotype revealed no deletions, translocations or
truncations. We are currently determining if the gene is missing or inactive by southern
analysis and in situ hybridization respectively (karyotype data not shown).
Further investigation to determine the specific functions of Connexin 43 in primary
thyrocytes could suggest how the loss of this default connexin may contribute to thyroid
gland architecture and possibly thyroid physiology. Functional assessment of FRTL-5
cells will be addressed in future studies.

CHAPTER V
CONCLUSIONS

We have clearly established the extent of autoimmune disease in Lewis rats that
presents with low free T4 levels, anti-thyroid autoantibodies, lymphocytic infiltration
and MHC class II expression. EAT mimics human Hashimoto’s thyroiditis and has
provided a very good model to study thyroiditis.
Our original hypothesis was: Inflammation-induced infiltration results in tissue
disruption, reduces intimate cell contact and decreases gap junctional communication
thereby contributing to EAT. This finding reflects target tissue as a participant in the
disease process of EAT, which is contrary to the current view that regards it is a
passive victim of autoimmune disease.
We identified the expression of Connexins 43, 32 and 26 in normal thyrocytes
and demonstrated that diseased thyrocytes expressed low levels of protein and mRNA
for all three connexins. The loss of dye transfer demonstrated a loss of intercellular
communication.
We also observed a loss of Connexin 43 protein and mRNA in FRTL-5 cells
when we examined them to determine the validity of using these cells as an additional
control for primary thyrocytes. Our findings of absent Connexin 43 protein and
mRNA in FRTL-5 cells were surprising. The absence of Connexin 43 is reflective of
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the loss of communication in the monolayer organization. However, the Connexin 32
appears to transfer dye in the follicles where it is expressed. We conclude that the
absence of Connexin 43 may be responsible for the aberrancies documented in FRTL-5
cells.
To reiterate, in EAT diseased primary thyrocytes expressed low levels of
Connexins 43, 32 and 26. The reduced connexin localization in the plasma membrane
suggested an impairment of connexin assembly. Abnormal communication in EAT was
not due to a loss of physical disruption as it persisted in cultures despite the restoration
of contact between cells. Fibrosis was also not responsible, as communication was
reduced in Lewis rats within 6 weeks of induction wherein fibrosis was minimal.
The communication remained reduced despite the removal of cytokines and
lymphocytes in culture suggesting other factors are responsible for the target tissue
abnormalities. We demonstrated the thyroid target tissue is altered but not destroyed
which contradicts the currently accepted models of thyroiditis. These models state the
immune components cause tissue destruction and subsequently reduce thyroid function
(1,17). Since physical disruption and cytokines were eliminated as a possible cause for
the decreased communication our investigation was broadened to find other
mechanisms that could be responsible for this reduced communication in EAT.
Our evaluation of cultured thyrocytes demonstrated that diseased thyrocytes were
metabolically accelerated implicating a kinase activity. We found pKC activity was
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elevated with increased expression of pKC isozymes;a, |3, 5 and s and an induction of
disease-specific y and X isozymes, therefore demonstrating that protein expression was
responsible for the elevated pKC activity. These findings suggested that the different
isozymes may have specific functions in the disease process of EAT. pKA activity was
not significantly different. The cAMP-pKA pathway functioned normally.
Examination of the TSHr linkage demonstrated normal linkage and signal transduction.
On further testing, we clearly proved the elevated pKC activity was responsible
for the reduced communication observed in diseased thyrocytes. After successfully
establishing that Connexin 43-mediated communication is decreased in diseased
thyrocytes and was due to an elevated pKC activity caused by enhanced pKC isoform
expression, we evaluated other possible mechanisms that could increase pKC activity.
To determine if TSHr contributes to EAT, we evaluated its expression. There
were two subpopulations; one with low TSHr expression and the other with a high
TSHr expression. The diseased thyrocytes had 27% more cells that expressed TSH
receptors at a high density in comparison to non-diseased thyrocytes. However, the
TSHr does not appear to be linked to the elevated pKC activity. The lack of an
association between the increased pKC activity and the increased TSHr is important and
demonstrates that TSHr does not switch from activating pKA to pKC in autoimmune
thyroiditis. Our findings demonstrate that the target tissue is altered after an immune
attack which is sustained and thereafter contributes to AT. We have integrated
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complex information and made some definite conclusions with great therapeutic
potential for human autoimmune thyroiditis.

163

RECOMMENDATIONS FOR FUTURE INVESTIGATIONS

This interesting work has stimulated many questions. My efforts here are to
briefly consider the immediate unanswered questions. Most relevant of which is:
“What is causing the elevated pKC activity?” It will be important to determine if
protein synthesis of pKC isozymes is really enhanced or if instead protein stability is
increased by one or more factors. Additionally the increase in pKC isozymes will be
studied with the knowledge that two isozymes; y and X occur in diseased thyrocytes
only. We need to investigate the pKC gene, its regulation and how transcription.
translation and protein stability are consequently affected. What we do know about
pKC gene splice forms will need to be more thoroughly explored and investigated to
understand the new expression of isozymes y and X in particular.
The involvement of an autocrine mechanism including the identification of
disease-inducing factors will be investigated.
We need to further address the significance of the absence of Connexin 43 in
FRTL-5 cells to determine its effects on thyroid function.
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